Mea Kākau: Janice Evans
Lā O Ka Hana: 2 Iulai 2021
HōʻAno Hou I Ka Lā: 16 Nowemapa 2024
Anonim
BOLINHO DE ARROZ COM CENOURA
Wikiō: BOLINHO DE ARROZ COM CENOURA

Anter

ʻO ka hua waina ka hua citrus. Hoʻohana ka poʻe i ka hua, ka aila mai ka peel, a me nā extracts mai ka hua ma ke ʻano he lāʻau. Hoʻomaʻamaʻa ʻia ka hua kanu hua hua mai ka mauʻu grapefruit a me ka pulp i loaʻa ma ke ʻano he huahana by mai ka hana wai wai hua. Hoʻohui ʻia ka glycerin mea kanu i ka huahana hope loa e hōʻemi i ka acidity a me ka ʻawaʻawa.

Lawe pinepine ʻia ka huaʻona i ka waha no ka pohō o ke kaupaona. Hoʻohana ʻia ia no ka hānō, ke kōpaʻa kiʻekiʻe, ka maʻi ʻaʻai, a me nā ʻano ʻē aʻe he nui, akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i kēia mau hoʻohana ʻē aʻe.

I ka meaʻai a me nā mea inu, hoʻopau ʻia ka grapefruit ma ke ʻano he hua, wai, a hoʻohana ʻia ma ke ʻano he ʻala.

I ka hana ʻana, hoʻohana ʻia ka aila grapefruit a me nā hua hua ma ke ʻano he ʻala i loko o nā kopa a me nā mea hoʻonaninani. a ma ke ʻano he hoʻomaʻemaʻe home no nā huaʻai, nā lau, nā ʻiʻo, nā papa kuke, nā pā, a me nā mea ʻē aʻe.

I ka mahiʻai, hoʻohana ʻia ka hua kanu grapefruit e pepehi i ka bacteria a me ka fungus, e hakakā i ka ulu ʻana o ka pala, e luku i nā parasite i nā mea hānai holoholona, ​​e mālama i ka meaʻai a me ka wai disinfect

He mea nui e hoʻomanaʻo i ka hoʻopili maikaʻi ʻana o ka launa lāʻau me ka wai grapefruit. ʻOkoʻa ka kemika o ka huaʻulu e nā ʻano loli, nā ʻano ulu, a me ke kaʻina hana e lawe i ka wai momona. Ma mua o ka hoʻohui ʻana i ka hua waina i kāu papaʻai a i kāu papa inoa o nā lāʻau kūlohelohe, e nānā me kāu mea mālama ola inā lawe ʻoe i nā lāʻau.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no GRAPEFRUIT penei:


E kūpono paha no ...

  • Ka momona. Lawe i kahi huahana kikoʻī i loko o ka ʻalani ʻalani, ʻalani ʻalani, a me nā mea ʻemi grapefruit e hoʻoliʻiliʻi ai ke kaumaha o ke kino a me ka momona o ke kino i ka poʻe kaumaha. Hōʻike pū kekahi mau noiʻi e ʻai ana i ka huaora hou i kēlā me kēia lā e hoʻonui ai i ka pohō kaumaha o ka poʻe kaumaha.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

  • Asthma. Hōʻike kekahi mau noiʻi e ʻai ana i nā hua citrus C-rich cithus, me ka huaʻōlani a me nā mea ʻē aʻe, e hoʻomaikaʻi ai paha i ka hana māmā i ka poʻe me ka hānō. Akā ʻaʻole hōʻike nā noiʻi ʻē aʻe i kēia pono.
  • Eczema (atopic dermatitis). Hōʻike ka noiʻi mua i hiki i ka hua hua grapefruit ke hoʻoliʻiliʻi i ka paʻa paʻa ʻana, ka ʻaukā, a me ka hōʻoluʻolu ʻole o ka ʻōpū i ka poʻe me ka eczema. Pili paha kēia pōmaikaʻi i ka hopena o ka grapefruit ma nā bacteria koʻohau.
  • Kolesterol kiʻekiʻe. Hōʻike ka noiʻi mua i ka lawe ʻana i ka pectin grapefruit i kēlā me kēia lā no 16 mau pule e hōʻemi i ka nui o ke kōkōlika a me ka lakio o ka lipoprotein haʻahaʻa (LDL a i ʻole "ʻino") kolesterol i ka lipoprotein (HDL a i ʻole "maikaʻi") kolesterol i hoʻohālikelike ʻia i ka laina kumu.
  • Nā pae kiʻekiʻe o nā momona i kapa ʻia nā triglycerides i ke koko (hypertriglyceridemia). ʻO ka ʻai ʻana i hoʻokahi grapefruit i kēlā me kēia lā e hoʻoliʻiliʻi i ka nui o ke kōkōlika, lipoprotein haʻahaʻa (LDL a i ʻole "maikaʻi") kolesterol, a me nā pae triglyceride i nā poʻe me nā pae triglyceride kiʻekiʻe.
  • Nā Lice. Hōʻike ka noiʻi mua i ka noi ʻana i kahi shampoo i loaʻa ka grapefruit e lawe i ka lauoho o nā keiki no 10-20 mau minuke e luku i nā kika. Ke noi hou ʻana i ka shampoo 10 mau lā ma hope e kōkua i ka hemo ʻana i nā nits i koe.
  • Huehue.
  • Kaumaha.
  • ʻO nā hoʻopiʻi Digestive i ka poʻe me ka eczema.
  • ʻO ka paʻakikī o nā aʻa (atherosclerosis).
  • ʻEha poʻo.
  • Nā maʻi ʻino.
  • Māluhiluhi Muscle.
  • Kāohi ʻana i ka maʻi ʻaʻai.
  • Ke hāpai nei i ka ulu ʻana o ka lauoho.
  • ʻO Psoriasis.
  • Kaumaha.
  • Toning ka ʻili.
  • Nā maʻi hū ʻo Vaginal.
  • Nā kūlana ʻē aʻe.
Pono nā hōʻike hou aʻe e helu i ka pono o ka grapefruit no kēia mau hoʻohana.

ʻO Grapefruit kahi kumu o ka wikamina C, fiber, potassium, pectin, a me nā meaola ʻē aʻe. Loaʻa paha i kekahi mau ʻāpana nā hopena antioxidant i hiki ke kōkua i ka pale ʻana i nā hunaola mai ka hōʻino a hoʻēmi paha i ka cholesterol.

ʻAʻole maopopo pehea ka holo ʻana o ka ʻaila no ka hoʻohana lāʻau.

Ke lawe ʻia e ka waha: ʻO ka hua waina LIKELY SAFE i nā kālā i hoʻohana mau ʻia ma ke ʻano he meaʻai a SAFE MAU PONO ke lawe ʻia e ka waha me he lāʻau lā. Akā ʻo ka huaʻulu POSSIBLY UNSAFE ke lawe ʻia e ka waha i ka nui.

Inā lawe ʻoe i nā lāʻau, e nānā me kāu kauka olakino ma mua o ka hoʻohui ʻana i ka huaʻulu i kāu papaʻai a hoʻohana paha iā ia ma ke ʻano he lāʻau. Pākuʻi ka huawaina me ka papa inoa lōʻihi o nā lāʻau (e nānā "Aia paha nā pilina me nā lāʻau?" Ma lalo).

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻAʻole lawa ka ʻike e pili ana i ka hoʻohana ʻana o ka huaʻulu i ka wā hāpai a me ka hānai ʻana i ka umauma. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

Maʻi ʻaʻai umauma: Aia ka hopohopo e pili ana i ka palekana o ka inu ʻana i nā wai momona o ka huaʻumi. Hōʻike kekahi mau noiʻi e pili ana i nā wahine postmenopausal ka mea e ʻai i ka quart a ʻoi aku o ka wai momona i kēlā me kēia lā he 25% a 30% ka nui o ka manawa o ka ulu ʻana i ka maʻi ʻaʻai umauma. Hoʻoemi ka wai momona i ka haki ʻana o ka estrogen i ke kino a hoʻonui paha i nā pae estrogen i ke kino. Pono e noiʻi hou e hōʻoia i kēia mau hopena. Aia a ʻike ʻia ka mea hou aku, e hōʻalo i ka inu ʻana i nā wai momona o ka grapefruit, keu hoʻi inā he kanulau umauma ʻoe a i ʻoi aku paha ma mua o ka makaʻu maʻamau no ka ulu ʻana i ka maʻi ʻaʻai umauma.

Nā maʻi o ka puʻuwai puʻuwai: ʻO ka ʻai ʻana i ka wai grapefruit e hoʻonui ai i ka hiki no ka puʻuwai puʻuwai abnormal. Pono nā kānaka me kēia mau maʻi e hoʻopau i ka wai huaʻikuʻu i ka manawa kūpono.

Nā maʻi ʻaʻai Hormone a me nā kūlana: ʻO ka ʻai ʻana i ka nui o ka grapefruit e hoʻonui ai i ka pae o ka hormone a no laila e hoʻonui i ka makaʻu o nā kūlana koʻikoʻi o ka hormone. ʻO nā wahine me nā kūlana wīwī e hōʻalo i ka huaora.

Paʻi kuʻi ʻole: ʻO ka ʻai ʻana i ka nui o ka wai huaʻakai a i ʻole ka wai huaʻulu paha e hoʻomāhuahua ai i ke kuʻi puʻuwai ʻole. Mai hoʻohana i ka grapefruit inā loaʻa iā ʻoe kēia ʻano.

Mekia
Mai lawe i kēia hui ʻana.
Amiodarone (Cordarone)
Hiki i ka wai huaʻomaʻo ke hoʻonui i ka nui o ka amiodarone (Cordarone) a ke kino e komo ai. ʻO ka inu ʻana i ka wai momona i ka wā e lawe ana i ka amiodarone (Cordarone) e hoʻonui paha i nā hopena a me nā hopena ʻaoʻao. Hōʻalo i ka inu ʻana i ka wai wai mālamama inā lawe ʻoe i amiodarone (Cordarone).
Artemether (Artenam, Paluther)
Hōʻoki ke kino i ka artemether (Artenam, Paluther) e hoʻolei iā ia. Hiki i ka wai huaʻakai ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka artemether (Artenam, Paluther). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka artemether (Artenam, Paluther) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o artemether (Artenam, Paluther). Mai inu i ka wai o ka grapefruit inā ʻoe e lawe i ka artemether (Artenam, Paluther).
Atorvastatin (Lipitor)
ʻO Atorvastatin (Lipitor) kahi ʻano o ka hoʻohaʻahaʻa kolesterol i ʻike ʻia ma ke ʻano he "statin." Haki ke kino i ka atorvastatin (Lipitor) e kāpae aku iā ia. Hiki i ka wai momona ke hoʻoliʻiliʻi i ka wikiwiki o ke kino e wāwahi i ka atorvastatin (Lipitor). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka atorvastatin (Lipitor) e hoʻonui ai paha i nā hopena a me nā hopena ʻē aʻe o kēia lāʻau.
ʻO Buspirone (BuSpar)
E hoʻonui paha ka wai huaʻai i ka nui o ka buspirone (BuSpar) e komo ai ke kino. ʻO ka inu ʻana i ka wai huaʻomaʻo i ka lawe ʻana i ka buspirone (BuSpar) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o buspirone (BuSpar).
Carbamazepine (Tegretol)
E hoʻonui paha ka wai huaʻai i ka nui o ka carbamazepine (Tegretol) e ʻānai ke kino. ʻO ka inu ʻana i ka wai huaʻomaʻo i ka lawe ʻana i ka carbamazepine (Tegretol) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o ka carbamazepine (Tegretol).
Carvedilol (Coreg)
Haki ke kino iā carvedilol (Coreg) e kāpae iā ia. ʻO ka wai momona e like me ka mea e hōʻemi ana i ka wikiwiki o ke kino e wāwahi i ka carvedilol (Coreg). ʻO ka inu ʻana i ka wai grapefruit ʻoiai e lawe ana iā carvedilol (Coreg) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o carvedilol (Coreg).
ʻO Celiprolol (Celicard)
Hōʻike ka huaʻomaʻo e hoʻemi i ka nui o ka lawe ʻia o ka celiprolol (Celicard). Hoʻoemi paha kēia i ka maikaʻi o celiprolol (Celicard). Hoʻokaʻawale i ka lawelawe ʻana o celiprolol (Celicard) a me ka ʻai ʻana o ka grapefruit e 4 mau hola.
Cisapride (Propulsid)
Hiki i ka wai momona e hoʻoliʻiliʻi i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka cisapride (Propulsid). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka cisapride (Propulsid) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o cisapride (Propulsid).
ʻO Clomipramine (Anafranil)
Haki ke kino i ka clomipramine (Anafranil) e hemo ai. Hiki i ka wai momona ke hoʻemi i ka wikiwiki o ke kino e hoʻopau i ka clomipramine (Anafranil). ʻO ka lawe ʻana i ka wai momona me ka clomipramine (Anafranil) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o clomipramine (Anafranil).
ʻO Clopidogrel (Plavix)
ʻO Clopidogrel (Plavix) kahi mea hana. Pono e hoʻoulu i nā mea hana e ka kino e hana. Hōʻike ka Grapefruit e hoʻemi i ka nui o ka clopidogrel (Plavix) e hoʻoulu ʻia e ke kino. E alakaʻi paha kēia i kahi hopena hoʻemi o clopidogrel. Mai lawe i ka huaʻakai me clopidogrel.
Cyclosporine (Neoral, Sandimmune)
Hoʻonui paha ka huaʻomaʻo i ka nui o ka cyclosporine (Neoral, Sandimmune) ka omo ke kino. ʻO ka inu ʻana i ka wai huaʻomaʻo i ka lawe ʻana i ka cyclosporine (Neoral, Sandimmune) e hoʻonui paha i nā hopena ʻē aʻe o cyclosporine.
Dextromethorphan (Robitussin DM, a me nā mea ʻē aʻe)
Haki ke kino i ka dextromethorphan (Robitussin DM, nā mea ʻē aʻe) e kipaku iā ia. E hoʻemi paha ka huaʻomaʻo i ka wikiwiki o ke kino e wāwahi i ka dextromethorphan (Robitussin DM, a me nā mea ʻē aʻe). ʻO ka inu ʻana i ka wai o ka grapefruit ʻoiai ke lawe nei i ka dextromethorphan (Robitussin DM, nā poʻe ʻē aʻe) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o dextromethorphan (Robitussin DM, a me nā mea ʻē aʻe).
ʻO Estrogens
Haki ke kino i nā estrogens e kāpae iā lākou. ʻO ka wai momona e like me ka mea e hōʻemi ana i ka wikiwiki o ke kino e wāwahi i nā estrogens a hoʻonui i ka nui o ka hanu o ke kino. ʻO ka inu ʻana i ka wai momona a ʻo ka lawe ʻana i nā estrogens e hoʻonui ai i nā pae estrogen a me nā hopena ʻē aʻe e pili ana me ka estrogen e like me ka maʻi ʻaʻai umauma.

ʻO kekahi o nā pila estrogen me nā conjogated equine estrogens (Premarin), ethinyl estradiol, estradiol (Climara, Vivelle, Estring), a me nā mea ʻē aʻe.
Etoposide (VePesid)
E hoʻemi paha ka huaʻoma i ka nui o ka etoposide (VePesid) i lawe ʻia e ke kino. ʻO ka inu ʻana i ka wai o ka grapefruit i ka lawe ʻana i ka etoposide (VePesid) e hoʻoliʻiliʻi paha i ka maikaʻi o ka etoposide (VePesid). I mea e hōʻalo ai i kēia pilina, hoʻokaʻawale i ka lawe ʻana i kēia lāʻau mai ka ʻai ʻana i ka grapefruit ma 4 mau hola.
Halofantrine
Haki ke kino i ka halofantrine e hemo ai. ʻO ka wai momona e like me ka mea e emi ai ka wikiwiki o ke kino e haki i ka halofantrine. ʻO ka inu ʻana i ka wai momona i ka wā e lawe ana i ka halofantrine e hoʻonui ai i nā pae halofantrine a me nā hopena ʻē aʻe e pili ana i ka halofantrine, me ka puʻuwai puʻuwai.
Lovastatin (Mevacor)
ʻO Lovastatin (Mevacor) kahi ʻano o ka hoʻohaʻahaʻa kolesterol i ʻike ʻia ma ke ʻano he "statin." Haki ke kino i ka lovastatin (Mevacor) e kāpae iā ia. E hoʻemi paha ka wai huaʻai i ka wikiwiki o ka wāwahi o ke kino i ka lovastatin (Mevacor). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka lovastatin (Mevacor) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o kēia lāʻau.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 3A4 (CYP3A4) substrates)
Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ka wai huaʻai i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. ʻO ka inu ʻana i ka wai o ka grapefruit ʻoiai ke lawe nei i kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o kekahi mau lāʻau. Ma mua o ka lawe ʻana i ka hua waina, e kamaʻilio me kāu kauka inā ʻoe e lawe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa me ka lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), a me nā mea ʻē aʻe he nui.
Nā lāʻau no ke koko kiʻekiʻe (Calcium channel blockers)
E hoʻonui paha ka wai huaʻai i ka nui o ka lāʻau no ke kaomi kiʻekiʻe e komo ai ke kino. ʻO ka inu ʻana i ka wai o ka grapefruit ʻoiai ke lawe nei i kekahi mau lāʻau no ke koko kiʻekiʻe e hoʻohaʻahaʻa loa i kou kahe koko.

ʻO kekahi mau lāʻau no ke koko kiʻekiʻe e komo pū me nifedipine (Adalat, Procardia), verapamil (Calan, Isoptin, Verelan), diltiazem (Cardizem), isradipine (DynaCirc), felodipine (Plendil), amlodipine (Norvasc), a me nā mea ʻē aʻe.
Neʻe ʻia nā lāʻau e nā pauma i nā hunaola (Organic anion-transporting polypeptide substrates)
Hoʻoneʻe ʻia kekahi mau lāʻau e nā pauma i nā hunaola. E loli paha ka huakea i ka hana ʻana o kēia mau pauma a hoʻemi i ka nui o kekahi o nā lāʻau i lawe ʻia e ke kino. Hiki i kēia ke hōʻemi i ka hopena o kēia mau lāʻau. I mea e hōʻalo ai i kēia pilina, hoʻokaʻawale i ka lawe ʻana i kēia mau lāʻau mai ka ʻai ʻana i ka grapefruit e 4 mau hola.

ʻO kekahi o kēia mau lāʻau i hoʻoneʻe ʻia e nā pumps i nā pūnaewele e komo pū me bosentan (Tracleer), celiprolol (Celicard, a me nā mea ʻē aʻe), etoposide (VePesid), fexofenadine (Allegra), antibiotic fluoroquinolone, glyburide (Micronase, Diabeta), irinotecan (Camptosar), methotrexate , paclitaxel (Taxol), saquinavir (Fortovase, Invirase), rifampin, statins, talinolol, torsemide (Demadex), troglitazone, and valsartan (Diovan).
Nā lāʻau i hiki ke kumu i kahi puʻuwai puʻuwai ʻole (QT interval-hoʻolōʻihi ʻia i nā lāʻau)
Hiki i ka huaʻakai ke hoʻopili i ka mana o kou puʻuwai. ʻO ka lawe ʻana i ka huaʻakai me nā lāʻau i hiki ke kumu i ka puʻuwai kūlohelohe ʻole ke kumu i nā hopena koʻikoʻi, e like me ka puʻuwai puʻuwai ʻole.
ʻO kekahi mau lāʻau e hiki ai ke kumu i ka puʻuwai kūlike ʻole me amiodarone (Cordarone), disopyramide (Norpace), dofetilide (Tikosyn), ibutilide (Corvert), procainamide (Pronestyl), quinidine, sotalol (Betapace), thioridazine (Mellaril), a me nā mea ʻē aʻe he nui.
Nā lāʻau i hoʻohana ʻia no ka hoʻohaʻahaʻa ʻana i ka cholesterol (Statins)
Uha ka kino i kekahi mau lāʻau hoʻohaʻahaʻa kolesterol i kapa ʻia ʻo "statins" e kāpae aku iā lākou. E hoʻemi paha ka wai huaʻai i ka wikiwiki o ka wāwahi o ke kino i nā "statins". ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i kekahi mau "statins" e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o kēia mau lāʻau.
Me he mea lā e hoʻēmi ka huaʻomaʻo i ka wikiwiki o ka haki o ke kino i kekahi mau "statins" me ka lovastatin (Mevacor), simvastatin (Zocor), a me atorvastatin (Lipitor)
Methadone (Dolophine)
Haki ke kino i ka methadone (Dolophine) e hemo ai. Hiki i ka wai huaʻomaʻo ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka methadone (Dolophine). ʻO ka inu ʻana i ka wai o ka grapefruit ʻoiai e lawe ana i ka methadone (Dolophine) hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o ka methadone (Dolophine).
Methylprednisolone
Haki ke kino i ka methylprednisolone e kāpae iā ia. Hiki i ka wai huaʻakai ke hoʻemi i ka wikiwiki o ke kino e hemo ai i ka methylprednisolone. ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka methylprednisolone e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o ka methylprednisolone.
Praziquantel (Biltricide)
Hōʻoki ke kino i ka praziquantel (Biltricide) e kāpae iā ia. Hiki i ka wai huaʻakai ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka praziquantel (Biltricide). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka praziquantel (Biltricide) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o praziquantel (Biltricide).
Quinidine
Haki ke kino i ka quinidine e hemo ai. E hoʻemi paha ka wai o ka huakea i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka quinidine. ʻO ka inu ʻana i ka wai momona i ka wā e lawe ana i ka quinidine e hoʻonui ai i ka manawa o nā hopena.
Scopolamine (Transderm Scop)
Haki ke kino i ka scopolamine e kāpae iā ia. Hiki i ka wai huaʻomaʻo ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka scopolamine. ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka scopolamine e hoʻonui ai paha i nā hopena a me nā hopena ʻē aʻe o scopolamine.
Nā lāʻau lapaʻau hōʻoluʻolu (Benzodiazepines)
Hiki i nā lāʻau lapaʻau hōʻoluʻolu ke hana i ka hiamoe a me ka hiamoe. Hiki i ka wai huaʻomaʻo ke hoʻemi i ka wikiwiki o ke kino e wāwahi i kekahi mau lāʻau hoʻohiamoe. ʻO ka inu ʻana i ka wai o ka grapefruit ʻoiai ke lawe nei i nā lāʻau hoʻohiamoe hiki ke hoʻonui i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau hoʻohiamoe.

ʻO kekahi mau lāʻau lapaʻau sedative (benzodiazepines) e launa pū paha me ka wai momona e komo pū me diazepam (Valium), midazolam (Versed), quazepam (Doral), a me triazolam (Halcion).
Sildenafil (Viagra)
Haki ke kino i ka sildenafil (Viagra) e kāpae iā ia. Hiki i ka huakea ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka sildenafil (Viagra). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka sildenafil (Viagra) hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o sildenafil (Viagra).
Simvastatin (Zocor)
Hōʻoki ke kino i ka simvastatin (Zocor) e kāpae iā ia. Hiki i ka wai momona ke hoʻoliʻiliʻi i ka wikiwiki o ke kino e wāwahi i ka simvastatin (Zocor). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka simvastatin (Zocor) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o kēia lāʻau.

ʻO Tacrolimus (Prograf)
Haki ke kino i ka tacrolimus (Prograf) e kāpae iā ia. Hiki i ka huakea ke hoʻoliʻiliʻi i ka wikiwiki o ke kino e haki i ka tacrolimus (Prograf).ʻO ka ʻai ʻana i ka huaʻulu a me ka inu ʻana i ka wai momona i ka wā e lawe ana i ka tacrolimus (Prograf) hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o tacrolimus (Prograf) Hōʻalo i ka ʻai ʻana i ka huaʻulu a inu paha i ka wai waiʻulu ke lawe ʻoe i ka tacrolimus.
ʻO Terfenadine (Seldane)
Hiki i ka huaʻomaʻo ke hoʻonui i ka nui o ka terfenadine (Seldane) a ke kino e komo ai. ʻO ka inu ʻana i ka wai huaʻomaʻo i ka lawe ʻana i terfenadine (Seldane) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o terfenadine (Seldane).
ʻO Ticagrelor (Brilinta)
Haki ke kino i ka ticagrelor (Brilinta) e kāpae iā ia. Hiki i ka huakea ke hoʻoliʻiliʻi i ka wikiwiki o ke kino e wāwahi i ka ticagrelor (Brilinta). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka ticagrelor (Brilinta) hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o ticagrelor (Brilinta).
Kānāwai
E akahele me kēia hui ʻana.
Aliskiren (Tekturna, Rasilez)
Hoʻoneʻe ʻia ʻo Aliskiren (Tekturna, Rasilez) e nā pauma i nā hunaola i loko o ke kino. Hiki ke hoʻololi i ka hua waina i ka hana ʻana o kēia mau pauma a hoʻemi i ka nui o ka aliskiren (Tekturna, Rasilez) e lawe ʻia e ke kino. Hiki i kēia ke hōʻemi i ka lāʻau. I mea e hōʻalo ai i kēia pilina, hoʻokaʻawale i ka lawe ʻana i kēia lāʻau mai ka ʻai ʻana i ka grapefruit ma 4 mau hola.
Blonanserin (Lonasen)
Haki ke kino i ka blonanserin (Lonasen) e kāpae iā ia. E hoʻonui paha ka huaʻoma i ka nui o ka blonanserin (Lonasen) lawe ke kino a hoʻoliʻiliʻi i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka blonanserin (Lonasen). ʻO ka inu ʻana i ka grapefruit ʻoiai ke lawe nei i ka blonanserin (Lonasen) e hoʻonui ai paha i nā hopena o ka blonanserin (Lonasen).
Budesonide (Entocort, UCERIS)
Haki ke kino i ka budesonide (Pulmicort) e hemo iā ia. E hoʻopau paha ka huaʻomaʻo i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka budesonide (Pulmicort). ʻO ka inu ʻana i ka grapefruit ʻoiai ke lawe nei i ka budesonide (Pulmicort) hiki ke hoʻonui i nā hopena ʻaoʻao o budesonide (Pulmicort).
Kāpena
Hōʻoki ke kino i ka caffeine e kāpae iā ia. E hoʻopau paha ka huaʻomaʻo i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka caffeine. ʻO ka inu ʻana i ka grapefruit ʻoiai e lawe ana i ka caffeine e hoʻonui ai i nā hopena o ka caffeine e like me ka jitteriness, headache, a me ka puʻuwai wikiwiki.
Colchisin
Hōʻoki ke kino i ka colchinika e hoʻopau iā ia. E hoʻemi paha ka huakea i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka colchicine. Akā kekahi mau noiʻi e hōʻike ana ʻaʻole e hoʻemi ka grapefruit i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka colchicine. Aia a ʻike ʻia ka mea hou aku, e hāhai i nā ʻōkuhi āpau e pili ana i ka huaʻōlele e pili ana i ka lawe ʻana i ka huaora.
ʻO Dapoxetine (Priligy)
Haki ke kino i ka dapoxetine (Priligy) e kāpae iā ia. Hiki i ka wai huaʻomaʻo ke hoʻemi i ka wikiwiki o ke kino e hoʻopau i ka dapoxetine (Priligy). Lawe i ka wai momona a me ka dapoxetine (Priligy) e hoʻonui i nā hopena a me nā hopena ʻē aʻe o dapoxetine.
ʻErythromycin
Hōʻoki ke kino i ka erythromycin e kāpae iā ia. Hiki i ka huakea ke hoʻoliʻiliʻi i ka wikiwiki o ke kino i ka erythromycin. Lawe i ka wai momona a me ka erythromycin e hoʻonui i nā hopena a me nā hopena ʻē aʻe o ka erythromycin.
Fexofenadine (Allegra)
E hoʻemi paha ka huaʻoma i ka nui o ka fexofenadine (Allegra) e komo ai ke kino. ʻO ka inu ʻana i ka wai huaʻomaʻo i ka lawe ʻana i ka fexofenadine (Allegra) e hoʻoliʻiliʻi paha i ka maikaʻi o fexofenadine (Allegra). I mea e hōʻalo ai i kēia pilina, hoʻokaʻawale i ka lawe ʻana i kēia lāʻau mai ka ʻai ʻana i ka grapefruit ma 4 mau hola.
Fluvoxamine (Luvox)
Hiki i ka wai huaʻomaʻo ke hoʻonui i ka nui o ka fluvoxamine (Luvox) a ke kino e komo ai. ʻO ka inu ʻana i ka wai momona i ka wā e lawe ana i ka fluvoxamine (Luvox) e hoʻonui ai paha i nā hopena a me nā hopena ʻē aʻe o fluvoxamine (Luvox).
Itraconazole (Sporanox)
Hoʻohana ʻia ʻo Itraconazole (Sporanox) e mālama i nā maʻi fungal. Hiki paha i ka wai huaʻomaʻo ke hoʻopili i ka nui o ka itraconazole (Sporanox) ka omo o ke kino. Akā ʻaʻole lawa ka ʻike e ʻike ai inā he hopohopo nui kēia pilina.
Levothyroxine (Synthroid, kekahi)
Hoʻoneʻe ʻia ʻo Levothyroxine (Synthroid, nā mea ʻē aʻe) e nā pauma i nā hunaola i loko o ke kino. Hiki ke hoʻololi i ka hua waina i ka hana ʻana o kēia mau pauma a hoʻemi i ka nui o ka levothyroxine (Synthroid, a me nā mea ʻē aʻe) e komo i ke kino. Hiki i kēia ke hōʻemi i ka lāʻau. I mea e hōʻalo ai i kēia pilina, hoʻokaʻawale i ka lawe ʻana i kēia lāʻau mai ka ʻai ʻana i ka grapefruit ma 4 mau hola.
Losartan (Cozaar)
Hoʻoulu ke akepaʻa iā losartan (Cozaar) e hana ai. Hiki i ka wai momona ke hoʻoliʻiliʻi i ka wikiwiki o ke kino e hoʻoulu ai iā losartan (Cozaar). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka losartan (Cozaar) e hoʻoliʻiliʻi paha ka maikaʻi o ka losartan.
Ua hoʻololi ʻia nā lāʻau e ke ake (Cytochrome P450 1A2 (CYP1A2) substrates)
Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ka wai huaʻai i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. ʻO ka lawe ʻana i ka wai grapefruit me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa hiki ke hoʻonui i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Ma mua o ka lawe ʻana i ka wai huaʻōlio e kamaʻilio me kāu kauka inā mālama ʻoe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ʻo amitriptyline (Elavil), haloperidol (Haldol), ondansetron (Zofran), propranolol (Inderal), theophylline (Theo-Dur, a me nā mea ʻē aʻe), verapamil (Calan, Isoptin, a me nā mea ʻē aʻe).
Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2C19 (CYP2C19) substrates)
Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ka wai huaʻai i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. ʻO ka lawe ʻana i ka wai grapefruit me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa hiki ke hoʻonui i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Ma mua o ka lawe ʻana i ka wai huaʻōlio e kamaʻilio me kāu kauka inā mālama ʻoe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa pū kekahi me ka omeprazole (Prilosec), lansoprazole (Prevacid), a me ka pantoprazole (Protonix); diazepam (Valium); carisoprodol (Soma); nelfinavir (Viracept); a me kekahi poʻe ʻē aʻe.
Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2C9 (CYP2C9) substrates)
Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ka wai huaʻai i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. ʻO ka lawe ʻana i ka wai grapefruit me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa hiki ke hoʻonui i nā hopena a me nā hopena ʻaoʻao o kekahi mau lāʻau. Ma mua o ka lawe ʻana i ka wai huaʻōlio i ke kauka lawelawe inā lawe ʻoe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa me diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), a me piroxicam (Feldene); celecoxib (Celebrex); amitriptyline (Elavil); warfarin (Coumadin); glipizide (Glucotrol); losartan (Cozaar); a me kekahi poʻe ʻē aʻe.
Nadolol (Corgard)
Neʻe ʻia ʻo Nadolol (Corgard) e nā pauma i nā hunaola i loko o ke kino. Hiki ke hoʻololi i ka hua waina i ka hana ʻana o kēia mau pauma a hoʻēmi i ka nui o ka lawe ʻia ʻana o ka nadolol (Corgard) e ke kino. Hiki i kēia ke hōʻemi i ka lāʻau. Eia nō naʻe, hōʻike kekahi mau noiʻi ʻaʻole pili ka grapefruit i ka nui o ka nui o ka nadolol (Corgard) e komo ai i ke kino. Aia a ʻike ʻia ka mea hou aʻe, e hāhai i nā ʻōkuhi ma ka lepela nadolol (Corgard) e pili ana i ka lawe ʻana i ka huaʻulu.
Nilotinib (Tasigna)
Hiki i ka wai huaʻomaʻo ke hoʻonui i ka nui o Nilotinib (Tasigna) a ke kino e omo ai. ʻO ka inu ʻana i ka wai huaʻikuʻi i ka lawe ʻana iā Nilotinib (Tasigna) e hoʻonui paha i nā hopena a me nā hopena ʻaoʻao. Hōʻalo i ka inu ʻana i ka wai wai mālamama inā lawe ʻoe iā Nilotinib (Tasigna).
Oxycodone (ʻoxycontin)
Hōʻoki ke kino i ka oxycodone (Oxycontin) e kāpae iā ia. Hiki i ka wai huaʻomaʻo ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka oxycodone (Oxycontin). ʻO ka inu ʻana i ka wai huaʻomaʻo i ka lawe ʻana i ka oxycodone (Oxycontin) e hoʻonui paha i nā hopena a me nā hopena ʻaoʻao o Oxycodone (Oxycontin).
Pitavastatin (Livalo)
Haki ke kino i ka pitavastatin (Livalo) e kāpae iā ia. E hoʻemi paha ka wai huaʻai i ka wikiwiki o ke kino e wāwahi i ka pitavastatin (Livalo). ʻO ka inu ʻana i ka wai huaʻikuʻi i ka lawe ʻana i ka pitavastatin (Livalo) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o kēia lāʻau.

Primaquine
Hiki i ka wai huaʻulu ke hoʻonui i ka nui o ka primaquine i loaʻa i loko o ke kino. ʻAʻole maopopo i nā hopena o kēia. E akahele me kēia hui ʻana.
ʻO Saquinavir (Fortovase, Invirase)
Hiki i ka inu ʻana i ka wai momona ke hoʻonui i ka nui o ka saquinavir (Fortovase, Invirase) ka omo o ke kino. ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka saquinavir (Fortovase, Invirase) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o ka saquinavir.
Sertraline (Zoloft)
Hōʻoki ke kino i ka sertraline e kāpae iā ia. Hiki i ka huakea ke hoʻoliʻiliʻi i ka wikiwiki o ke kino e wāwahi i ka sertraline. ʻO ka inu ʻana i ka wai o ka grapefruit ʻoiai ke lawe nei i ka sertraline hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o sertraline.
ʻO Sunitinib (Sutent)
Haki ke kino i ka sunitinib (Sutent) e hemo iā ia. E hoʻemi paha ka wai o ka huakea i ka wikiwiki o ka haki o ke kino i ka sunitinib (Sutent). ʻO ka inu ʻana i ka wai huaʻikuʻi i ka lawe ʻana i sunitinib (Sutent) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o sunitinib (Sutent). Akā hōʻike kekahi mau noiʻi ʻaʻole ka hopohopo nui ka hopena o ka huaʻulu i ka sunitinib (Sutent). Aia a ʻike ʻia ka mea hou aku, e hāhai i nā ʻōkuhi ma ka lepili sunitinib (Sutent) e pili ana i ka lawe ʻana i ka huaora.
Talinolol
Hiki i ka wai huʻu limu ke hoʻemi i ka nui o ka talinolol i loaʻa i loko o ke kino. ʻO ka inu ʻana i ka wai momona me ka talinolol e hōʻemi paha i nā hopena o ka talinolol.
ʻO Theophylline
E hoʻemi paha ka inu ʻana i ka wai o ka grapefruit i nā hopena o theophylline. ʻAʻole lawa ka ʻike e ʻike ai inā he hopohopo nui kēia.
Tolvaptan (Samsca)
Haki ke kino i ka tolvaptan (Samsca) e hemo ai. Hiki i ka huakea ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka tolvaptan (Samsca). ʻO ka inu ʻana i ka wai huaʻikuʻi ʻoiai e lawe ana i ka tolvaptan (Samsca) hiki ke hoʻonui i nā hopena a me nā hopena ʻaoʻao o tolvaptan (Samsca).
Warfarin (Coumadin)
Hoʻohana ʻia ʻo Warfarin (Coumadin) e hoʻolohi i ke kāpili ʻana o ke koko. Hiki paha i ka inu ʻana i ka wai momona ke hoʻonui i nā hopena o warfarin (Coumadin) a hoʻonui i ka manawa o ka palapū a me ke kahe ʻana o ke kahe. E nānā pono e nānā pinepine i kou koko. Pono e hoʻololi i ka hopena o kāu warfarin (Coumadin).
Mea liʻiliʻi
E makaʻala me kēia hui pū.
Acebutolol (Sectral)
Hoʻoneʻe ʻia ʻo Acebutolol (Sectral) e nā pauma i nā hunaola i loko o ke kino. Hiki ke hoʻololi i ka hua waina i ka hana ʻana o kēia mau pauma a hoʻoliʻiliʻi i ka nui o ka lawe ʻia ʻana o ka acebutolol (Sectral) e ke kino. Hiki i kēia ke hōʻemi i ka lāʻau. I mea e hōʻalo ai i kēia pilina, hoʻokaʻawale i ka lawe ʻana i kēia lāʻau mai ka ʻai ʻana i ka grapefruit ma 4 mau hola.
Amprenavir (Agenerase)
E hoʻemi iki paha ka huaʻoma i ka nui o ka amprenavir (Agenerase) i ke kino. Akā ʻaʻole paha kēia hopohopo i mea hopohopo nui.
Laikini
ʻO ka inu ʻana i ka wai o ka grapefruit ke lawe i ka licorice e hoʻonui ai i ka hiki o ka laikini e hana i ka make potassium.
Hū ʻula
Hoʻololi ka huaʻulu (wai a hua paha) i ke ʻano o ke kino e hana ai i ka hū ʻulaʻula. Hiki i ka hua waina ke hoʻonui i ka nui o ka lovastatin mai ka hū ʻulaʻula i loko o ke koko.
Kumulāʻau akua
Aia i loko o ke kumu waina ʻo Thunder ka triptolide. Haki ke kino i ka triptolide e kāpae iā ia. Hiki i ka huakea ke hoʻoliʻiliʻi i ka wikiwiki o ke kino e haki i ka triptolide. ʻO ka inu ʻana i ka wai momona i ka wā e lawe ana i ka kumulāʻau akua thunder i loaʻa i ka triptolide e hoʻonui ai i nā hopena a me nā hopena ʻē aʻe o ke kumu waina thunder.
Wai Tonic
Hoʻopilikia paha ka huaʻai i ke ʻano o ke kino e hana ai i ka quinine i loko o ka wai tonic. ʻO ka poʻe i loaʻa kahi maʻi o ka puʻuwai puʻuwai (lōʻihi QT syndrome, ʻo kahi laʻana) pono e hōʻalo i ka lawe pū ʻana i ka huaora a me ka wai tonic, ʻoiai e hōʻeha paha kēlā ʻano i ko lākou puʻuwai.
Waina
E hoʻemi paha ka wai huaʻai i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Hoʻonui paha kēia i nā hopena ʻaoʻao o kēia mau lāʻau. Hiki i ka hoʻohui ʻana i ka waina ʻulaʻula i ka hoʻohuihui ke hoʻonui i kēia mau hopena ʻē aʻe i ka nui aʻe. ʻAʻole naʻe e hui pū ka waina keʻokeʻo me ka grapefruit a i ʻole nā ​​lāʻau i wāwahi ʻia e ke ake.
Ua aʻo ʻia nā mahele aʻe i ka noiʻi ʻepekema:

E ka waha:
  • No ka momona: 450-700 mg o kahi huahana kikoʻī i loko o ka ʻalani ʻalani, ʻalani ʻalani, a me nā mea ʻemi grapefruit ʻelua mau manawa i kēlā me kēia lā no 12 mau pule i hoʻohana ʻia. ʻO ka ʻai ʻana i ka hapalua o ka grapefruit ʻekolu mau manawa i kēlā me kēia lā, inu i ka 8 auneke o ka wai huaʻiku i ʻekolu manawa i kēlā me kēia lā, a i ʻole ka lawe ʻana i nā capsule i piha i ka hua waina maloʻo maloʻo 500 mg ʻekolu manawa ma mua o ka ʻai ʻana no 12 mau pule.
ʻO Bioflavonoid Complex, Bioflavonoid Concentrate, Bioflavonoid Extract, Bioflavonoids, Bioflavonoïdes, Bioflavonoïdes d'grumes, Citrus Bioflavones, Citrus Bioflavonoid, Citrus Bioflavonoid Extract, Citrus Bioflavonoids, Citrus Citrus Citrus, Citrus Citrus Citrus, Citrus Citrus ʻO kaʻaila huawaina kaomi ʻia, ʻoihana Bioflavonoïde, ʻo Bioflavonoïde de Pamplemousse, ʻo Concentré de Bioflavonoïde, ʻo CSE, ʻo kaʻaila huawaina i hōʻike ʻia, ʻo Extrait de Bioflavonoïde, ʻo Extrait de Bioflavonoïdes dʻAgrume, ʻo Extrait de Graines de Pamplemousse, ʻo Extrait de Pamplemousse, ʻo Extrait de Pamplemousse, ʻo Extrait de Pamplemousse 'Agrume, Grapefruit Bioflavonoid Complex, Grapefruit Extract, Grapefruit Oil, Grapefruit Seed Extract, Grapefruit Seed Glycerate, GSE, Huile de Pamplemousse, Huile de Pamplemousse Presse à Froid, Pamplemousse, Pamplemousse Rose, Paradisapfel, Pink Grapefruit, Mexican Greloef, ʻO Shaddock ʻAilika, ʻĀina Exquised o Grapefruit, Toronja.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.


  1. Ershad M, Cruz MD, Mostafa A, Mckeever R, Vearrier D, Greenberg MI. ʻO ka Opioid toxidrome ma hope o ka pau ʻana o ka wai huaʻiku i ka hoʻonohonoho ʻana o ka mālama methadone. J Addict Med 2019; [Epub ma mua o ka paʻi]. Nānā kiʻi ʻole.
  2. ʻO Chorin E, Hochstadt A, Granot Y, et al. Hoʻolōʻihi ke kīʻaha wai i ka wā QT o nā manawaleʻa olakino a me nā mea maʻi me ka maʻi QT lōʻihi. Puʻuwai Heart. 2019. pii: S1547-527130368-6. Nānā kiʻi ʻole.
  3. Shang DW, Wang ZZ, Hu HT, et al. Nā hopena o ka meaʻai a me ka wai o ka grapefruit ma nā lāʻau lapaʻau hoʻokahi wale nō o blonanserin i nā kumuhana Kina olakino. ʻO Eur J Clin Pharmacol. 2018; 74: 61-67. Nānā kiʻi ʻole.
  4. Santes-Palacios R, Romo-Mancillas A, Camacho-Carranza R, Espinosa-Aguirre JJ. ʻO ka pāpā ʻana i ke kanaka a me ka ʻiole CYP1A1 enzyme e nā hui wai wai huaʻalani. ʻO Toxicol Lett. 2016 Sep 6; 258: 268-75. Nānā kiʻi ʻole.
  5. Kawaguchi-Suzuki M, Nasiri-Kenari N, Shuster J, et al. Ka hopena o ka hoʻohaʻahaʻa wai momona momona furanocoumarin haʻahaʻa ma nā lāʻau lapaʻau midazolam. ʻO J Clin Pharmacol. 2017 Malaki; 57: 305-11. Nānā kiʻi ʻole.
  6. Melough MM, Vance TM, Lee SG, et al. ʻO nā kinetics ʻo Furocoumarin i ka plasma a me ka mimi o nā mākua olakino e ukali nei i ka ʻai ʻana o ka huaʻulu (citrus paraiso Macf.) A me ka wai huaʻulu. ʻO J Agric Meaʻai Kemika. 2017 Mar 29 [Epub ma mua o ka paʻi] Nānā abstract.
  7. ʻO Jia Y, Liu J, Xu J. Ka hopena o ka wai huaʻalani ma nā lāʻau lapaʻau lāʻau o ka triptolide i loko o nā ʻiole wai momona i nā hopena o triptolide. ʻO Xenobiotica. 2017 Apr 16: 1-5. Nānā kiʻi ʻole.
  8. ʻO Abdlekawy KS, Donia AM, Elbarbry F. Nā hopena o ka huaora a me nā wai pomeraite ma nā waiwai pharmacokinetic o dapoxetine a me midazolam i nā kumuhana olakino. ʻO Eur J ʻOihana Metab Pharmacokinet. 2017 Iune; 42: 397-405. Nānā kiʻi ʻole.
  9. Tsuji H, Ohmura K, Nakashima R, et al. Ka maikaʻi a me ka palekana o ka lawe ʻana i ka wai grapefruit me ka mālama ʻana i ka tacrolimus i nā mea maʻi maʻi pili. ʻO Med Med. 2016; 55: 1547-52. Nānā kiʻi ʻole.
  10. ʻO Hung WL, Suh JH, Wang Y. ʻO ke kelekema a me nā hopena olakino o furanocoumarins i ka huaʻōlani. J ʻAi ʻAi ʻAi ʻAi. 2017 Ian; 25: 71-83. Nānā kiʻi ʻole.
  11. Mouly S, Lloret-Linares C, Sellire PO, Sene D, Bergmann JF. ʻO ke kaulike kaulike o ka launa lāʻau-meaʻai a me nā launa lāʻau lau lāʻau i kaupalena ʻia i ka wai huaʻōlani a me Saint-John's Wort? ʻO Pharmacol Res. 2017 Apr; 118: 82-92. Nānā kiʻi ʻole.
  12. ʻO Bailey DG. Ke wānana nei i ka pilina olakino o nā launa lāʻau grapefruit-drug: kahi hana paʻakikī. ʻO J Clin Pharm Ther. 2017 ʻAropa; 42: 125-27. Nānā kiʻi ʻole.
  13. Dallas C, Gerbi A, Elbez Y, Caillard P, Zamaria N, Cloarec M. Ke aʻo pilikino e loiloi i ka hopena a me ka palekana o kahi citrus polyphenolic extract o ka ʻalani ʻulaʻula, grapefruit, a me ka ʻalani (Sinetrol-XPur) e pili ana i ka hoʻokele kaumaha a me nā metabolic parameter. i ke olakino kaumaha kanaka. ʻO Phytother Res. 2014 Pepeluali; 28: 212-8. Nānā kiʻi ʻole.
  14. Dallas C, Gerbi A, Tenca G, Juchaux F, Bernard FX. ʻO ka hopena Lipolytic o kahi polyphenolic citrus kahi maloʻo maloʻo o ka ʻalani ʻulaʻula, huaʻalani, ʻalani (SINETROL) i loko o nā kino momona o ke kino kanaka. ʻO ka hana o ka hana e ka pāpā ʻana i ka cAMP-phosphodiesterase (PDE). Phytomedicine. 2008 ʻOkakopa; 15: 783-92. Nānā kiʻi ʻole.
  15. ʻO Dahan A, ʻAmidon GL. Hoʻonui ka wai momona i ka wai momona a me nā mea pili i ka lawe ʻana i ka ʻōpū o ka ʻōpū: hiki i ka pilina weliweli a me ka hana o p-glycoprotein. ʻO Pharm Res. 2009 ʻApela; 26: 883-92. Nānā kiʻi ʻole.
  16. ʻO Goldbart A, Press J, Sofer S, Kapelushnik J. Ma kahi kokoke i ka ʻona ʻana o ka colchicine fatal i kahi keiki. He hōʻike hihia. Eur J Pediatr. 2000; 159: 895-7. Nānā kiʻi ʻole.
  17. Peterson JJ, Beecher GR, Bhagwat SA, et al. Flavanones i ka grapefruit, nā lemona, a me nā lime: kahi hōʻuluʻulu a me ka loiloi o ka ʻikepili mai nā palapala anamanaʻo. J ʻAilana Comp Anal. 2006; 19: S74-S80.
  18. Xiao YJ, Hu M, Tomlinson B. Nā hopena o ka wai huaʻalani ma cortisol metabolism i nā kāne kāne Kina olakino olakino. Meaʻai Chem Toxicol. 2014 Dec; 74: 85-90. Nānā kiʻi ʻole.
  19. van Erp NP, Baker SD, Zandvliet AS, Ploeger BA, den Hollander M, Chen Z, den Hartigh J, König-Quartel JM, Guchelaar HJ, Gelderblom H. Hoʻonui i ka maritinal o ka sunitinib e ka wai momona. ʻO Kauka Chemother Pharmacol. 2011 Malaki; 67: 695-703. Nānā kiʻi ʻole.
  20. ʻO Tapaninen T, Neuvonen PJ, Niemi M. ʻO ka wai momona e hoʻoliʻiliʻi nui i ka nui o ka plasma o ka OATP2B1 a me CYP3A4 substrate aliskiren. ʻO Clin Pharmacol Ther. 2010 Sep; 88: 339-42. Nānā kiʻi ʻole.
  21. Tanaka S, Uchida S, Miyakawa S, Inui N, Takeuchi K, Watanabe H, Namiki N. Ka hoʻohālikelike ʻana o ka lōʻihi o ka wai huaʻola i ka polypeptide-transporting polypeptide a me cytochrome P450 3A4. ʻO Biol Pharm Bull. 2013; 36: 1936-41. Nānā kiʻi ʻole.
  22. ʻO Shoaf SE, Mallikaarjun S, ʻo Bricmont P. Ka hopena o ka wai momona i nā lāʻau lapaʻau lāʻau pono o tolvaptan, kahi non-peptide arginine vasopressin antagonist, i nā kumuhana olakino. ʻO Eur J Clin Pharmacol. 2012 Pepeluali; 68: 207-11. Nānā kiʻi ʻole.
  23. Seidegård J, Randvall G, Nyberg L, Borgå O. ʻO ka wai wai huakō me ka budesonide waha: ka hopena like i ka hoʻokuʻu koke ʻana a me nā hoʻolālā hoʻokuʻu lohi. ʻO Pharmazie. 2009 Jul; 64: 461-5. Nānā kiʻi ʻole.
  24. ʻO Piccirillo G, Magrì D, Matera S, Magnanti M, Pasquazzi E, Schifano E, Velitti S, Mitra M, Marigliano V, Paroli M, Ghiselli A. Nā hopena o ka wai ʻalani momona ma ka QT loli i nā mea maʻi me ka dilomy a hypertensive cardiomyopathy a i kumuhana ola. Unuhi Res. 2008 Mei; 151: 267-72. Nānā kiʻi ʻole.
  25. Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT. Hoʻonui ka wai huaʻoma i ka ʻike ʻana i ka oxycodone waha. ʻO ka Clinical Clinacol Toxicol maʻamau. 2010 ʻOkakopa; 107: 782-8. Nānā kiʻi ʻole.
  26. Misaka S, Miyazaki N, Yatabe MS, Ono T, Shikama Y, Fukushima T, Kimura J. Pharmacokinetic a me ka launa lāʻau pharmacodynamic o nadolol me itraconazole, rifampicin a me ka wai momona i nā mea manawaleʻa olakino. ʻO J Clin Pharmacol. 2013 Jul; 53: 738-45. Nānā kiʻi ʻole.
  27. ʻO Ieiri I, Doi Y, Maeda K, Sasaki T, Kimura M, Hirota T, Chiyoda T, Miyagawa M, Irie S, Iwasaki K, Sugiyama Y. Ke aʻo ʻana i ka lāʻau lapaʻau microdosing: ʻo ka pharmacokinetic, ʻo ka pharmacogenomic (SLCO2B1), a me ka launa pū ʻana (wai momona) nā moʻolelo o celiprolol ma hope o ka microdose waha a me ka lāʻau lapaʻau. ʻO J Clin Pharmacol. 2012 Jul; 52: 1078-89. Nānā kiʻi ʻole.
  28. Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B. Nā hopena o ka wai grapefruit a me SLCO1B1 388A> G polymorphism ma nā pharmacokinetics o pitavastatin. ʻO ka lāʻau lapaʻau Metab Pharmacokinet. 2013; 28: 104-8. Nānā kiʻi ʻole.
  29. ʻO Holmberg MT, Tornio A, Neuvonen M, Neuvonen PJ, Backman JT, Niemi M. ʻO ka wai momona ka mea e kāohi i ka hoʻoweliweli metabolic o clopidogrel. ʻO Clin Pharmacol Ther. 2014 Malaki; 95: 307-13. Nānā kiʻi ʻole.
  30. Holmberg MT, Tornio A, Joutsi-Korhonen L, Neuvonen M, Neuvonen PJ, Lassila R, Niemi M, Backman JT. Hoʻonui ka wai momona i ka nui o ka plasma concentrations a me nā hopena antiplatelet o ticagrelor i nā kumuhana olakino. ʻO Br J Clin Pharmacol. 2013 Iune; 75: 1488-96. Nānā kiʻi ʻole.
  31. ʻO Abdel-Ghaffar F, Semmler M, Al-Rasheid K, Klimpel S, Mehlhorn H. Ka hopena o kahi hua grapefruit ma nā kihi poʻo: kahi hoʻokolokolo hoʻokolokolo. ʻO Parasitol Res. 2010 Ian; 106: 445-9. Nānā kiʻi ʻole.
  32. ʻO Ionescu G, Kiehl R, Wichmann-Kunz F, a me et al. Lawe ʻia ka hua citrus citrus ma atopic eczema: in vitro a me nā ʻike vivo e pili ana i ka microflora ʻōpū. ʻO J Orthomol Med 1990; 5: 155-157.
  33. Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A., a me Rouseff, R. L. Flavanone omo ma hope o naringin, hesperidin, a me ka lawelawe ʻana i ka citrus. ʻO Clin Pharmacol Ther 1996; 60: 34-40. Nānā kiʻi ʻole.
  34. ʻO Pisarik, P. Ka hoʻohaʻahaʻa ʻana i ke kahe o ka hoʻohui ʻana i ka wai o ka grapefruit i nifedipine a me terazosin i ka mea maʻi me ka hanu kiʻekiʻe. ʻO Arch Fam. Med 1996; 5: 413-416. Nānā kiʻi ʻole.
  35. ʻO Curhan, G. C., Willett, W. C., Rimm, E. B., Spiegelman, D., a me Stampfer, M. J. Ke aʻo kūpono ʻana i ka hoʻohana ʻana i ka mea inu a me ka makaʻu o nā pōhaku kōkō. ʻO Am J Epidemiol. 2-1-1996; 143: 240-247. Nānā kiʻi ʻole.
  36. Cerda, J. J., Normann, S. J., Sullivan, M. P., Burgin, C. W., Robbins, F. L., Vathada, S., a me Leelachaikul, P. Kaohi ʻana i ka atherosclerosis e ka pectin dietary i microswine me ka hypercholesterolemia i hoʻomau ʻia. Kaapuni 1994; 89: 1247-1253. Nānā kiʻi ʻole.
  37. Baekey, P. A., Cerda, J. J., Burgin, C. W., Robbins, F. L., Rice, R. W., a me Baumgartner, T. G. ʻO Grapefruit pectin e kāohi i ka hypercholesterolemia a me atherosclerosis i nā puaʻa liʻiliʻi. ʻO Clin Cardiol 1988; 11: 597-600. Nānā kiʻi ʻole.
  38. ʻO McLundie, A. C. ʻO ka nalowale ʻana o ka niho palatal a me ka mālama ʻana me nā lamineka porcelain. Hoʻihoʻi Hou. 1991; 7: 43-44. Nānā kiʻi ʻole.
  39. Guo, LQ, Chen, QY, Wang, X., Liu, YX, Chu, XM, Cao, XM, Li, JH, a me Yamazoe, Y. Nā ʻano ʻokoʻa o ka pummelo furanocoumarin a me ka cytochrome P450 3A5 * 3 polymorphism i ka hopena a me ka hana o felodipine. ʻO Curr Metab 2007; 8: 623-630. Nānā kiʻi ʻole.
  40. Ferdman, R. M., Ong, P. Y., a me Church, J. A. Pectin anaphylaxis a me ka hui pū paha me ka allergy cashew. ʻO Ann. Allergy Asthma Immunol. 2006; 97: 759-760. Nānā kiʻi ʻole.
  41. Fujioka, K., Greenway, F., Sheard, J., a me Ying, Y. Nā hopena o ka huaora i ke kaupaona a me ke kūpaʻa ʻana o ka insulin: ka pilina me ka metabolic syndrome. ʻO J Med Food 2006; 9: 49-54. Nānā kiʻi ʻole.
  42. Gorinstein, S., Caspi, A., Libman, I., Lerner, HT, Huang, D., Leontowicz, H., Leontowicz, M., Tashma, Z., Katrich, E., Feng, S., a Trakhtenberg, S. ʻO ka huaʻalani ʻulaʻula e hoʻohuli maikaʻi i ka pae triglyceride serum i nā mea maʻi e ʻeha ana i ka atherosclerosis coronary: nā noiʻi ma vitro a me nā kānaka. ʻO J Agric Food Chem 3-8-2006; 54: 1887-1892. Nānā kiʻi ʻole.
  43. Kumar, A., Teuber, S. S., Naguwa, S., Prindiville, T., and Gershwin, M. E. Eosinophilic gastroenteritis and citrus-induced urticaria. ʻO Clin Rev Allergy Immunol 2006; 30: 61-70. Nānā kiʻi ʻole.
  44. Armanini, D., Calo, L., a me Semplicini, A. Pseudohyperaldosteronism: nā hana pathogenetic. ʻO Crit Rev Clin Lab Lab 2003; 40: 295-335. Nānā kiʻi ʻole.
  45. Palermo, M., Armanini, D., a me Delitala, G. Loaʻa ka wai momona i ka 11beta-hydroxysteroid dehydrogenase in vivo, i ke kāne. ʻO Clin Endocrinol. (Oxf) 2003; 59: 143-144. Nānā kiʻi ʻole.
  46. Wangensteen, H., Molden, E., Christensen, H., a me Malterud, K. E. Kuhi ʻia o epoxybergamottin ma ke ʻano he mea kāohi ʻo CYP3A4 i ka ʻili grapefruit. Eur J Clin Pharmacol 2003; 58: 663-668. Nānā kiʻi ʻole.
  47. Trinchieri, A., Lizzano, R., Bernardini, P., Nicola, M., Pozzoni, F., Romano, AL, Serrago, MP, a me Confalanieri, S. Ka hopena o ka ukana huakō o ka wai momona ma ka urinary excretion o citrate. a me nā kumu pilikia urinary no ka hoʻokumu ʻana i ka pōhaku renal. ʻO Dig.Liver Dis. 2002; 34 Hōʻuluʻulu 2: S160-S163. Nānā kiʻi ʻole.
  48. Sardi, A., Geda, C., Nerici, L., a me Bertello, P. [Rhabdomyolysis a me ka hypertension arterial i hoʻokumu ʻia e ka mea i ʻoi aku ka nui o nā mineralocorticoids: kahi hōʻike hihia]. Ann Ital Med Int 2002; 17: 126-129. Nānā kiʻi ʻole.
  49. Bailey, D. G., Dresser, G. K., Kreeft, J. H., Munoz, C., Freeman, D. J., a me Bend, J. R. Grapefruit-felodipine launa pū: ka hopena o nā hua i hoʻomākaukau ʻole ʻia a me nā mea hana kūpono. ʻO Clin Pharmacol Ther 2000; 68: 468-477. Nānā kiʻi ʻole.
  50. Wason, S., DiGiacinto, J. L., a me Davis, M. W. Nā hopena o ka huaʻalani a me nā wai ʻalani ʻo Seville ma nā waiwai pharmacokinetic o colchisin i nā kumuhana olakino. ʻO Clin Ther 2012; 34: 2161-2173. Nānā kiʻi ʻole.
  51. ʻO Kiani, J. a me Imam, S. Z. He mea nui ka lāʻau o ka wai grapefruit a me ka launa pū ʻana me nā lāʻau like ʻole. ʻO Nutr.J. 2007; 6:33. Nānā kiʻi ʻole.
  52. ʻO Odou, P., Ferrari, N., Barthelemy, C., Brique, S., Lhermitte, M., Vincent, A., Libersa, C., a me Robert, H. Grapefruit wai-nifedipine hui pū: hiki ke komo i kekahi mau ʻanoʻano hana. ʻO J Clin Pharm Ther 2005; 30: 153-158. Nānā kiʻi ʻole.
  53. Desta, Z., Kivisto, K. T., Lilja, J. J., Backman, J. T., Soukhova, N., Neuvonen, P. J., a me Flockhart, D. A. Stereoselective pharmacokinetics o cisapride i nā mea manawaleʻa olakino a me ka hopena o ka mālama pinepine ʻana i ka wai huaʻōlani. ʻO Br J Clin Pharmacol 2001; 52: 399-407. Nānā kiʻi ʻole.
  54. ʻO Kivisto, K. T., Lilja, J. J., Backman, J. T., a me Neuvonen, P. J. Hoʻonui pinepine ʻia ka hoʻohana ʻana i ka wai huaʻalani e hoʻonui ai i ka nui o ka waiola ma ka cisapride. ʻO Clin Pharmacol Ther 1999; 66: 448-453. Nānā kiʻi ʻole.
  55. Lilja, J. J., Laitinen, K., a me Neuvonen, P. J. Nā hopena o ka wai huaʻalani i ka lawe ʻana o ka levothyroxine. Br J Clin Pharmacol 2005; 60: 337-341. Nānā kiʻi ʻole.
  56. Glaeser, H., Bailey, DG, Dresser, GK, Gregor, JC, Schwarz, UI, McGrath, JS, Jolicoeur, E., Lee, W., Leake, BF, Tirona, RG, a me Kim, RB Intestinal drug transporter 'ōlelo a me ka hopena o ka wai huaʻiku i ke kanaka. ʻO Clin Pharmacol Ther 2007; 81: 362-370. Nānā kiʻi ʻole.
  57. Sigusch, H., Henschel, L., Kraul, H., Merkel, U., a me Hoffmann, A. Ka nele o ka hopena o ka wai huaʻalani ma ka diltiazem bioavailability i nā kumuhana maʻamau. Pharmazie 1994; 49: 675-679. Nānā kiʻi ʻole.
  58. Paine, MF, Widmer, WW, Hart, HL, Pusek, SN, Beavers, KL, Criss, AB, Brown, SS, Thomas, BF, a me Watkins, PB A furanocoumarin-free grapefruit wai hoʻokumu furanocoumarins ma ke ʻano he waena o ka grapefruit hui wai-felodipine. 'Am J Clin Nutr 2006; 83: 1097-1105. Nānā kiʻi ʻole.
  59. Yee, G. C., Stanley, D. L., Pessa, L. J., Dalla, Costa T., Beltz, S. E., Ruiz, J., a me Lowenthal, D. T. Ka hopena o ka wai huaʻakeʻake i ke kōkiko cyclosporin. Lancet 4-15-1995; 345: 955-956. Nānā kiʻi ʻole.
  60. ʻO Schwarz, U. I., Johnston, P. E., Bailey, D. G., Kim, R. B., Mayo, G., a me Milstone, A. Ka hopena o nā mea inu ʻona citrus e pili ana i ka wai momona ma ka ciclosporin ʻano. ʻO Br J Clin Pharmacol 2006; 62: 485-491. Nānā kiʻi ʻole.
  61. Lee, M., Min, D. I., Ku, Y. M., a me Flanigan, M. Ka hopena o ka wai huaʻalani ma luna o nā pharmacokinetics o microemulsion cyclosporine i nā kumuhana ʻApelika ʻAmelika i hoʻohālikelike ʻia me nā kumuhana Caucasian: he mea nui ka ʻokoʻa lāhui? ʻO J Clin Pharmacol 2001; 41: 317-323. Nānā kiʻi ʻole.
  62. Ku, Y. M., Min, D. I., a me Flanigan, M. Ka hopena o ka wai o ka grapefruit ma luna o nā pharmacokinetics o microemulsion cyclosporine a me kāna metabolite i nā mea manawaleʻa olakino: he mea nui ka hoʻolālā? ʻO J Clin Pharmacol 1998; 38: 959-965. Nānā kiʻi ʻole.
  63. Ducharme, M. P., Warbasse, L. H., a me Edwards, D. J. Hoʻolilo i ka cyclosporine intravenous a me oral ma hope o ka lawelawe ʻana me ka wai grapefruit. ʻO Clin Pharmacol Ther 1995; 57: 485-491. Nānā kiʻi ʻole.
  64. ʻO Bistrup, C., Nielsen, F. T., Jeppesen, U. E., a me Dieperink, H. Ka hopena o ka wai o ka huaʻalani ma ka Sandimmun Neoral lawe ʻia i waena o nā mea loaʻa allograft paʻa. Hoʻololi Neprol. 2001; 16: 373-377. Nānā kiʻi ʻole.
  65. Uno, T., Ohkubo, T., Motomura, S., a me Sugawara, K. Ka hopena o ka wai momona i ka hana o nā enantiomers manidipine i nā kumuhana olakino. Br J Clin Pharmacol 2006; 61: 533-537. Nānā kiʻi ʻole.
  66. ʻO Rashid, J., McKinstry, C., Renwick, A. G., Dirnhuber, M., Waller, D. G., a me George, C. F. Quercetin, kahi in vitro inhibitor o CYP3A, ʻaʻole i hāʻawi i ka pilina ma waena o ka nifedipine a me ka wai grapefruit. Br J Clin Pharmacol 1993; 36: 460-463. Nānā kiʻi ʻole.
  67. Soons, PA, Vogels, BA, Roosemalen, MC, Schoemaker, HC, Uchida, E., Edgar, B., Lundahl, J., Cohen, AF, a me Breimer, DD wai momona a me ka cimetidine e kāohi i ka metabolism stereoselective o nitrendipine i loko o kānaka. . ʻO Clin Pharmacol Ther 1991; 50: 394-403. Nānā kiʻi ʻole.
  68. Rashid, T. J., Martin, U., Clarke, H., Waller, D. G., Renwick, A. G., a me George, C. F. Nā mea e pili ana i ka bioavailability loa o ka nifedipine. Br J Clin Pharmacol 1995; 40: 51-58. Nānā kiʻi ʻole.
  69. Lundahl, J., Undersh, C. G., Edgar, B., a me Johnsson, G. Ka pilina ma waena o ka manawa o ka lawe ʻana i ka wai huaʻakeʻake a me kona hopena ma nā pharmacokinetics a me nā pharmacodynamics o felodipine i nā kumuhana olakino. Eur J Clin Pharmacol 1995; 49 (1-2): 61-67. Nānā kiʻi ʻole.
  70. Lundahl, J., Undersh, C. G., Edgar, B., a me Johnsson, G. Nā hopena o ka inu ʻana o ka wai huaʻakeʻake - nā pharmacokinetics a me nā haemodynamics o felodipine i lawelawe a haʻi waha ʻia i nā kāne olakino. Eur J Clin Pharmacol 1997; 52: 139-145. Nānā kiʻi ʻole.
  71. Hashimoto, K., Shirafuji, T., Sekino, H., Matsuoka, O., Sekino, H., Onnagawa, O., Okamoto, T., Kudo, S., a me Azuma, J. Ka launa pū ʻana o nā wai ʻalani me pranidipine, he 1,4-dihydropyridine calcium antagonist hou, i nā kumuhana olakino. Eur J Clin Pharmacol 1998; 54 (9-10): 753-760. Nānā kiʻi ʻole.
  72. Fuhr, U., Maier-Bruggemann, A., Blume, H., Muck, W., Unger, S., Kuhlmann, J., Huschka, C., Zaigler, M., Rietbrock, S., a me Staib, Hoʻonui ka wai huaʻai AH i ka bioavailability oral nimodipine. Int J Clin Pharmacol Ther 1998; 36: 126-132. Nānā kiʻi ʻole.
  73. ʻO Goosen, TC, Cillie, D., Bailey, DG, Yu, C., He, K., Hollenberg, PF, Woster, PM, Cohen, L., Williams, JA, Rheeders, M., a me Dijkstra, HP Bergamottin kōkua i ka launa pū ka wai-felodipine a me ke ʻano i ke kanaka. ʻO Clin Pharmacol Ther 2004; 76: 607-617. Nānā kiʻi ʻole.
  74. ʻO Edgar, B., Bailey, D., Bergstrand, R., Johnsson, G., a me About, C. G. Nā hopena koʻikoʻi o ka inu ʻana i ka wai huaʻōlani ma luna o nā pharmacokinetics a me nā dynamics o felodipine - a me ka mea hiki ke pili pono i ka lāʻau. Eur J Clin Pharmacol 1992; 42: 313-317. Nānā kiʻi ʻole.
  75. ʻO Christensen, H., Asberg, A., Holmboe, A. B., a me Berg, K. J. ʻO ka mālama ʻana i ka wai huaʻalani e hoʻonui ai i ka hōʻike ʻōnaehana o diltiazem i nā mea manawaleʻa olakino. Eur J Clin Pharmacol 2002; 58: 515-520. Nānā kiʻi ʻole.
  76. Bailey, D. G., Arnold, J. M., Bend, J. R., Tran, L. T., a me Spence, J. D. Grapefruit wai-felodipine launa: reproducibility a me characterization me ka hoʻolōʻihi hoʻokuʻu lāʻau formulate. ʻO Br J Clin Pharmacol 1995; 40: 135-140. Nānā kiʻi ʻole.
  77. Bailey, D. G., Arnold, J. M., Munoz, C., a me Spence, J. D. Grapefruit wai - felodipine pilina: ʻano hana, wānana, a me ka hopena o naringin. ʻO Clin Pharmacol Ther 1993; 53: 637-642. Nānā kiʻi ʻole.
  78. Schwarz, U. I., Seemann, D., Oertel, R., Miehlke, S., Kuhlisch, E., Fromm, M. F., Kim, R. B., Bailey, D. G., a me Kirch, W. ʻO ka inu ʻana i ka wai hua ʻole e hoʻoliʻiliʻi i ka bioavailability talinolol. ʻO Clin Pharmacol Ther 2005; 77: 291-301. Nānā kiʻi ʻole.
  79. Sugimoto, K., Araki, N., Ohmori, M., Harada, K., Cui, Y., Tsuruoka, S., Kawaguchi, A., a me Fujimura, A. ʻO ka hana ma waena o ka wai momona a me nā lāʻau hypnotic: hoʻohālikelike o triazolam a me quazepam. Eur J Clin Pharmacol 2006; 62: 209-215. Nānā kiʻi ʻole.
  80. ʻO Hugen, PW, Burger, DM, Koopmans, PP, Stuart, JW, Kroon, FP, van Leusen, R., a me Hekster, YA Saquinavir capsules palupalu-gel (Fortovase) hāʻawi i ka hōʻike haʻahaʻa ma mua o ka mea i manaʻo ʻia, ʻoiai ma hope o kahi momona nui ʻaina kakahiaka. ʻO ka Honua Honua Sci 2002; 24: 83-86. Nānā kiʻi ʻole.
  81. Culm-Merdek, KE, von Moltke, LL, Gan, L., Horan, KA, Reynolds, R., Harmatz, JS, Court MH, a me Greenblatt, DJ Ka hopena o ka hoʻolōʻihi ʻia ʻana i ka wai huaʻalani ma ka hana cytochrome P450 3A i nā kānaka. : hoʻohālikelike me ritonavir. ʻO Clin Pharmacol Ther 2006; 79: 243-254. Nānā kiʻi ʻole.
  82. Cuong, B. T., Binh, V. Q., Dai, B., Duy, D. N., Lovell, C. M., Rieckmann, K. H., a me Edstein, M. D. Hoʻololi paha ke kāne, ka meaʻai a i ʻole ka wai momona i nā mea hana lāʻau lapaʻau o ka primaquine i nā kumuhana olakino? Br J Clin Pharmacol 2006; 61: 682-689. Nānā kiʻi ʻole.
  83. Charbit, B., Becquemont, L., Lepere, B., Peytavin, G., a me Funck-Brentano, C. Pharmacokinetic a me ka launa lāʻau pharmacodynamic ma waena o ka wai momona a me ka halofantrine. ʻO Clin Pharmacol Ther 2002; 72: 514-523. Nānā kiʻi ʻole.
  84. Lilja, J. J., Neuvonen, M., a me Neuvonen, P. J. Nā hopena o ka hoʻohana mau ʻana o ka wai huaʻomaʻo i nā lāʻau lapaʻau o ka simvastatin. Br J Clin Pharmacol 2004; 58: 56-60. Nānā kiʻi ʻole.
  85. Ando, ​​H., Tsuruoka, S., Yanagihara, H., Sugimoto, K., Miyata, M., Yamazoe, Y., Takamura, T., Kaneko, S., a me Fujimura, A. Nā hopena o ka wai huaʻalani ma nā pharmacokinetics o pitavastatin a me atorvastatin. Br J Clin Pharmacol 2005; 60: 494-497. Nānā kiʻi ʻole.
  86. ʻO Clifford, C. P., Adams, D. A., Murray, S., Taylor, G. W., Wilkins, M. R., Boobis, A. R., a me Davies, D. S. Nā hopena cardiac o terfenadine ma hope o ka pāpā ʻia ʻana o kāna metabolism e ka wai huaʻalani. Eur J Clin Pharmacol 1997; 52: 311-315. Nānā kiʻi ʻole.
  87. Benton, R. E., Honig, P. K., Zamani, K., Cantilena, L. R., a me Woosley, R. L. Hoʻololi ka wai momona Grapefruit i nā farmokokinetics terfenadine, e hopena ana i ka hoʻolōʻihi ʻia o ka repolarization ma ka electrocardiogram. ʻO Clin Pharmacol Ther 1996; 59: 383-388. Nānā kiʻi ʻole.
  88. Kawakami, M., Suzuki, K., Ishizuka, T., Hidaka, T., Matsuki, Y., a me Nakamura, H. Ka hopena o ka wai huaʻakeʻake i nā pharmacokinetics o itraconazole i nā kumuhana olakino. Int J Clin Pharmacol Ther 1998; 36: 306-308. Nānā kiʻi ʻole.
  89. Lee, A. J., Chan, W. K., Harralson, A. F., Buffum, J., a me Bui, B. C. Nā hopena o ka wai huaʻalani i ka metabolism metabolist sertraline: kahi in vitro a me ka noiʻi vivo. ʻO Clin Ther 1999; 21: 1890-1899. Nānā kiʻi ʻole.
  90. ʻO Min, D. I., Ku, Y. M., Geraets, D. R., a me Lee, H. Ka hopena o ka wai huaʻalani ma nā pharmacokinetics a me nā pharmacodynamics o quinidine i nā manawaleʻa olakino. ʻO J Clin Pharmacol 1996; 36: 469-476. Nānā kiʻi ʻole.
  91. Libersa, CC, Brique, SA, Motte, KB, Caron, JF, Guedon-Moreau, LM, Humbert, L., Vincent, A., Devos, P., a me Lhermitte, MA Kākoʻo nui i ka amiodarone kūpona i hoʻokomo ʻia e ka wai huaʻake. . Br J Clin Pharmacol 2000; 49: 373-378. Nānā kiʻi ʻole.
  92. Kupferschmidt, H. H., Ha, H. R., Ziegler, W. H., Meier, P. J., a me Krahenbuhl, S. ʻO ka hana ma waena o ka wai momona a me midazolam i nā kānaka. ʻO Clin Pharmacol Ther 1995; 58: 20-28. Nānā kiʻi ʻole.
  93. ʻO Hukkinen, S. K., Varhe, A., Olkkola, K. T., a me Neuvonen, P. J. Plasma concentrations o triazolam e hoʻonui ʻia e ka lawe pū ʻana o ka wai momona. ʻO Clin Pharmacol Ther 1995; 58: 127-131. Nānā kiʻi ʻole.
  94. Andersen, V., Pedersen, N., Larsen, N. E., Sonne, J., a me Larsen, S. Hoʻouna mua ka Intestinal i ka metabolism o ka midazolam i ka cirrhosis ate - ka hopena o ka wai huaʻalani. Br J Clin Pharmacol 2002; 54: 120-124. Nānā kiʻi ʻole.
  95. ʻO Sigusch, H., Hippius, M., Henschel, L., Kaufmann, K., a me Hoffmann, A. Ka hopena o ka wai huaʻake i nā lāʻau lapaʻau lāʻau i ka hoʻokuʻu lohi nifedipine. Pōpala 1994; 49: 522-524. Nānā kiʻi ʻole.
  96. ʻO Hollander, AA, van Rooij, J., Lentjes, GW, Arbouw, F., van Bree, JB, Schoemaker, RC, van Es, LA, van der Woude, FJ, a me Cohen, AF Ka hopena o ka wai huaʻalani ma cyclosporine a me ka prednisone metabolism i nā maʻi transplant. ʻO Clin Pharmacol Ther 1995; 57: 318-324. Nānā kiʻi ʻole.
  97. Lilja JJ, Raaska K, Neuvonen PJ. Nā hopena o ka wai grapefruit ma nā pharmacokinetics o acebutolol. Br J Clin Pharmacol 2005; 60: 659-63. Nānā kiʻi ʻole.
  98. Yin OQ, Gallagher N, Li A, et al. Ka hopena o ka wai huaʻalani ma nā lāʻau lapaʻau lāʻau o nilotinib i nā mea komo i ke olakino. ʻO J Clin Pharmacol 2010; 50: 188-94. Nānā kiʻi ʻole.
  99. Benmebarek M, Devaud C, Gex-Fabry M, et al. Nā hopena o ka wai huaʻalani ma nā pharmokinetinetics o nā enantiomers o methadone. ʻO Clin Pharmacol Ther 2004; 76: 55-63. Nānā kiʻi ʻole.
  100. Hori H, Yoshimura R, Ueda N, et al. ʻO ka launa ʻana o ka wai momona-fluvoxamine - he makaʻu paha ia ʻaʻole paha? ʻO J Clin Psychopharmacol 2003; 23: 422-4. Nānā kiʻi ʻole.
  101. Yasui N, Kondo T, Furukori H, et al. Nā hopena o kaʻai pinepine ʻana o ka wai huaʻomaʻo ma ka hoʻokahi a me ka nui o nā lāʻau lapaʻau lāʻau-waha a me nā pharmacodynamics o alprazolam. Psychopharmacology (Berl) 2000; 150: 185-90. Nānā kiʻi ʻole.
  102. ʻO Demarles D, Gillotin C, Bonaventure-Paci S, et al. Hoʻokomo ʻia nā pharmacokinetics kū hoʻokahi o ka amprenavir me ka wai momona. Nā Antimicrob Agents Chemother 2002; 46: 1589-90. Nānā kiʻi ʻole.
  103. ʻIke huahana no Cordarone. ʻO Wyeth Pharmaceuticals, Inc.Piladelapia, PA 19101. Kepakemapa 2006.
  104. Bailey DG, Dresser GK, Leake BF, Kim RB. ʻO Naringin kahi mea kāohi i ka mea nui a koho i nā polypeptide 1A2 (OATP1A2) i loko o ka wai momona. ʻO Clin Pharmacol Ther 2007; 81: 495-502. Nānā kiʻi ʻole.
  105. ʻO Bailey DG. ʻO ka pāpā ʻana i ka wai huaʻai o ka lawe ʻana i ka lawe: kahi ʻano hou o ka launa pū me ka lāʻau. ʻO Br J Clin Pharmacol 2010; 70: 645-55. Nānā kiʻi ʻole.
  106. ʻO Greenblatt DJ. Ka nānā ʻana i nā launa lāʻau e pili ana i nā mea inu hua a me nā polypeptides anion-transporting organic. ʻO J Clin Pharmacol 2009; 49: 1403-7. Nānā kiʻi ʻole.
  107. ʻO Dresser GK, ʻo Kim RB, ʻo Bailey DG. Ka hopena o ka nui o ka wai o ka huaʻemi i ka hoʻoliʻiliʻi o ka bioavailability fexofenadine: hiki i ke kuleana o ka anion meaola e lawe ana i nā polypeptides. ʻO Clin Pharmacol Ther 2005; 77: 170-7. Nānā kiʻi ʻole.
  108. ʻO ka launa ʻana me nā lāʻau hiki ke hiki. Palapala a ka Pharmacist's Letter / Prescriber's Letter 2007; 23: 230204.
  109. Farkas D, Oleson LE, Zhao Y, et al. ʻAʻole hoʻopōʻino ka wai Pomegranate i ka ʻae o ka midazolam waha a i ʻole intravenous, kahi ʻimi no ka hana cytochrome P450-3A: hoʻohālikelike me ka wai momona. ʻO J Clin Pharmacol 2007; 47: 286-94. Nānā kiʻi ʻole.
  110. Monroe KR, Murphy SP, Kolonel LN, Pike MC. Ke aʻo kūpono ʻana i ka lawe ʻana i ka huaʻī a me ka makaʻu o ka maʻi ʻaʻai o ka umauma i nā wahine postmenopausal: ka Mutliethnic Cohort Study. ʻO Br J Cancer 2007; 97: 440-5. Nānā kiʻi ʻole.
  111. Zitron E, Scholz E, Owen RW, et al. QTc hoʻolōʻihi ʻia e ka wai huaʻiku a me ke kumu pono lāʻau: hiki i ke kahawai HERG e nā flavonoids. Kaapuni 2005; 835: 835-8. Nānā kiʻi ʻole.
  112. ʻO Unger M, Frank A. Hoʻoholo like i ka mana o ka extract potency o nā mea kanu lāʻau i ka hana o ʻeono nui cytochrome P450 enzyme e hoʻohana ana i ka chromatography wai / spectrometry lehulehu a me ka unuhi lima pūnaewele. Rapid Commun Mass Spectrom 2004; 18: 2273-81. Nānā kiʻi ʻole.
  113. ʻO Fukazawa I, ʻo Uchida N, ʻo Uchida E, ʻo Yasuhara H. Nā hopena o ka wai huaʻalani i nā lāʻau lapaʻau o ka atorvastatin a me ka pravastatin i ka ʻōlelo Kepanī. ʻO Br J Clin Pharmacol 2003; 57: 448-55. Nānā kiʻi ʻole.
  114. Sullivan DM, Ford MA, Boyden TW. ʻO ka wai huawaina a me ka pane o warfarin. ʻO Am J Health-Syst Pharm 1998; 55: 1581-3. Nānā kiʻi ʻole.
  115. ʻO Gaudineau C, Beckerman R, Welbourn S, Auclair K. Kaohi ʻana i nā enzyme P450 kanaka e nā mea nui o ka Ginkgo biloba extract. ʻO Biochem Biophys Res Comm 2004; 318: 1072-8. Nānā kiʻi ʻole.
  116. ʻO Bailey DG, Dresser GK, Bend JR. Bergamottin, wai lime, a me ka waina ʻulaʻula e like me nā mea kaohi o ka hana cytochrome P450 3A4: hoʻohālikelike me ka wai momona. ʻO Clin Pharmacol Ther 2003; 73: 529-37. Nānā kiʻi ʻole.
  117. ʻO Di Marco MP, ʻo Edwards DJ, ʻo Wainer IW, ʻo MP Ducharme. ʻO ka hopena o ka wai huaʻalani a me ka wai ʻalani seville ma luna o nā pharmacokinetics o dextromethorphan: ke kuleana o ka ʻōpū CYP3A a me P-glycoprotein. Life Sci 2002; 71: 1149-60. Nānā kiʻi ʻole.
  118. Parker RB, Yates CR, Soberman JE, Laizure SC. Nā hopena o ka wai grapefruit ma ka P-glycoprotein ʻōpū: loiloi e hoʻohana ana i ka digoxin i loko o nā kānaka. Pharmacotherapy 2003; 23: 979-87. Nānā kiʻi ʻole.
  119. ʻO Shelton MJ, Wynn HE, Hewitt RG, DiFrancesco R. Nā hopena o ka wai huaʻalani ma ka loaʻa ʻana o ka lāʻau lapaʻau i ka indinavir i nā kumuhana HIV-maikaʻi. ʻO J Clin Pharmacol 2001; 41: 435-42. Nānā kiʻi ʻole.
  120. ʻO Dresser GK, Bailey DG, Leake BF, et al. ʻO nā wai momona e kāohi i ka anion organik e lawe ana i ka lāʻau lāʻau polypeptide-mediated e hoʻemi i ka loaʻa o ka waha o fexofenadine. ʻO Clin Pharmacol Ther 2002; 71: 11-20. Nānā kiʻi ʻole.
  121. Becquemont L, Verstuyft C, Curb R, a me al. Ka hopena o ka wai huaʻalani ma nā digoxin pharmacokinetics i kānaka. ʻO Clin Pharmacol Ther 2001; 70: 311-6. Nānā kiʻi ʻole.
  122. ʻO Bailey DG, Dresser GK, Bend JR. Bergamottin, wai lime, a me ka waina ʻulaʻula e like me nā mea kaohi o ka hana cytochrome P450 3A4: hoʻohālikelike me ka wai momona. ʻO Clin Pharmacol Ther 2003; 73: 529-37. Nānā kiʻi ʻole.
  123. Veronese ML, Gillen LP, Burke JP, et al. ʻO ka pāpā ʻana i ka hopena o ka ʻōpū a me ka hepatic CYP3A4 i loko o vivo e ka wai momona. ʻO J Clin Pharmacol 2003; 43: 831-9. . Nānā kiʻi ʻole.
  124. Rogers JD, Zhao J, Liu L, et al. Loaʻa ka hopena liʻiliʻi o ka wai Grapefruit i ka hoʻopili ʻana o ka plasma o ka lovastatin i loaʻa iā 3-hydroxy-3-methylglutaryl coenzyme He mea hōʻemi reductase. ʻO Clin Pharmacol Ther 1999; 66: 358-66. Nānā kiʻi ʻole.
  125. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, et al. Nā mīkini o ka loaʻa ʻana o ka waha o CYP3A4 substrates hoʻonui ʻia e nā mea ʻoliʻoli. Hoʻoemi i ka enterositte CYP3A4 konsentration a me ka hana-i hoʻokumu ʻia e furanocoumarins. Ka Waihona Metab Lapaʻau 1997; 25: 1228-33. Nānā kiʻi ʻole.
  126. Edwards DJ, Fitzsimmons ME, Schuetz EG, et al. 6 ', 7'-Dihydroxybergamottin i ka wai huaʻikuʻu a me ka wai ʻalani ʻo Seville: nā hopena ma ke ʻano cyclosporine, enterocyte CYP3A4, a me P-glycoprotein. ʻO Clin Pharmacol Ther 1999; 65: 237-44. Nānā kiʻi ʻole.
  127. Penzak SR, Acosta EP, Turner M, et al. Ka hopena o ka wai ʻalani a Seville a me ka wai huaʻiku ma nā lāʻau lapaʻau indinavir. ʻO J Clin Pharmacol 2002; 42: 1165-70. Nānā kiʻi ʻole.
  128. Gupta MC, Garg SK, Badyal D, et al. Ka hopena o ka wai huaʻalani ma nā hale hana lāʻau lapaʻau o ka theophylline i nā kāne manawaleʻa olakino. E ʻike i nā hana hana i Exp Clin Pharmacol 1999; 21: 679-82. Nānā kiʻi ʻole.
  129. Greenblatt DJ, von Moltke LL, Harmatz JS. Ka papa manawa o ka hoʻōla o ka cytochrome P450 3A hana ma hope o hoʻokahi o nā kaha o ka wai huaʻiku. ʻO Clin Pharmacol Ther 2003; 74: 121-29. Nānā kiʻi ʻole.
  130. Hermans K, Stockman D, Van den Branden F. Grapefruit a me ka tonic: kahi hui make i ka mea maʻi me ka QT syndrome lōʻihi. 'Am J Med 2003; 114: 511-512.
  131. ʻO Reif S, Nicolson M, Bisset D, et al. Ka hopena o ka lawe ʻana i ka wai grapefruit ma ka bioavailability etoposide. Eur J Clin Pharmacol 2002; 58: 491-4 .. Nānā i ka abstract.
  132. Kanazawa S, Ohkubo T, Sugawara K. Nā hopena o ka wai grapefruit ma nā pharmacokinetics o erythromycin. Eur J Clin Pharmacol 2001; 56: 799-803. Nānā kiʻi ʻole.
  133. Fuhr U, Muller-Peltzer H, Kern R, et al. Nā hopena o ka wai momona a me ka uahi ʻana ma nā concentrations verapamil i ka mokuʻāina paʻa. Eur J Clin Pharmacol 2002; 58: 45-53. Nānā kiʻi ʻole.
  134. ʻO Ebert U, ʻo Oertel R, ʻo Kirch W. Ka hopena o ka wai huaʻalani ma scopolamine pharmokokinetics a me nā pharmacodynamics i nā kāne a me nā kumuhana wahine. Int J Clin Pharmacol Ther 2000; 38: 523-31. Nānā kiʻi ʻole.
  135. Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, et al. Nā hopena o ka wai grapefruit ma nā pharmacokinetics o sildenafil. ʻO Clin Pharmacol Ther 2002; 71: 21-9. Nānā kiʻi ʻole.
  136. Castro N, Jung H, Medina R, et al. Ka launa ma waena o ka wai momona a me ka praziquantel i loko o ke kanaka. ʻO Antimicrob Agents Chemother 2002; 46: 1614-6. Nānā kiʻi ʻole.
  137. Lilja JJ, Kivisto KT, Neuvonen PJ. Ka lōʻihi o ka hopena o ka wai momona ma nā pharmacokinetics o ka CYP3A4 substrate simvastatin. ʻO Clin Pharmacol Ther 2000; 68: 384-90. Nānā kiʻi ʻole.
  138. ʻO Bailey DG, Luna lole GK. Ka launa ʻana o ka wai hua-lovastatin. ʻO Clin Pharmacol Ther 2000; 67: 690. Nānā kiʻi ʻole.
  139. Uno T, Ohkubo T, Sugawara K, et al. Nā hopena o ka wai o ka grapefruit ma ke ʻano stereoselective o nicardipine i loko o kānaka: nā hōʻike no ka hoʻopau presystemic mana ma ka pūnaewele ʻōpū. Eur J Clin Pharmacol 2000; 56: 643-9. Nānā kiʻi ʻole.
  140. Ho PC, Ghose K, Saville D, Wanwimolruk S. Ka hopena o ka wai huaʻalani ma nā pharmacokinetics a me nā pharmodinnamics o nā verantiam enantiomers i nā limahana olakino olakino. Eur J Clin Pharmacol 2000; 56: 693-8. Nānā kiʻi ʻole.
  141. ʻO Chan WK, Nguyen LT, Miller VP, Harris RZ. ʻO ka hana ʻole o ka mekanism o ka cytochrome kanaka P450 3A4 e ka wai huaʻalani a me ka waina ʻulaʻula. Life Sci 1998; 62: PL135-42. Nānā kiʻi ʻole.
  142. ʻO Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics a me ka urinary excretion o nā flavanones naringenin a me hesperetin i loko o nā kānaka ma hope o kaʻai ʻana i ka wai ʻalani a me ka wai grapefruit. ʻO J Nutr 2001; 131: 235-41. Nānā kiʻi ʻole.
  143. Lilja JJ, Kivisto KT, Backman JT, Neuvonen PJ. Ka hopena o ka hopena o ka wai momona ma ka grapefruit wai-triazolam ka launa ʻana: hoʻolōʻihi ka ʻai ʻana i hoʻolōʻihi ʻia ka hapalua o ke ola o triazolam. Eur J Clin Pharmacol 2000; 56: 411-5. Nānā kiʻi ʻole.
  144. Bailey DG, Dresser GK, Munoz C, et al. Ka hoʻoliʻiliʻi o ka bioavailability fexofenadine e nā wai momona. ʻO Clin Pharmacol Ther 2001; 69: P21.
  145. ʻO Dresser GK, Bailey DG, Carruthers SG. ʻO ka launa ʻana o ka wai huaola-felodipine i ka poʻe ʻelemakule. ʻO Clin Pharmacol Ther 2000; 68: 28-34. Nānā kiʻi ʻole.
  146. Troisi RJ, Willett WC, Weiss ST, et al. A prospective hoʻopaʻa haʻawina o ka papaʻai a me nā mākua-hoʻomaka hānō. ʻO Am J Respir Crit Care Med 1995; 151: 1401-8. Nānā kiʻi ʻole.
  147. Butland BK, Fehily AM, Elwood PC. ʻO ka papaʻai, ka hana o ka māmā, a me ka hoʻohaʻahaʻa ʻana o ka hana i ka cohort o 2512 kāne kāne waena. ʻO Thorax 2000; 55: 102-8. Nānā kiʻi ʻole.
  148. ʻO Schwartz J, Weiss ST. Ka pilina ma waena o kaʻai wikamina C a me ka hana pulmonary i ka First National Health and Nutrition Examination Survey (NHANES I). ʻO Am J Clin Nutr 1994; 59: 110-4. Nānā kiʻi ʻole.
  149. Carey IM, Strachan DP, Cook DG. Nā hopena o nā loli i ka hoʻohana ʻana i nā hua hou i ka hana ventilatory i nā mākua Pelekane olakino. ʻO Am J Respir Crit Care Med 1998; 158: 728-33. Nānā kiʻi ʻole.
  150. Hatch GE. Asthma, inhal oxidants, a me dietary antioxidants. ʻO Am J Clin Nutr 1995; 61: 625S-30S. Nānā kiʻi ʻole.
  151. Forastiere F, Pistelli R, Sestini P, et al. ʻO kaʻai ʻana i nā huaʻai hou i waiwai i ka wikamina C a me nā ʻōuli o ke kani i nā keiki. ʻO Thorax 2000; 55: 283-8. Nānā kiʻi ʻole.
  152. Von Woedtke T, Schluter B, Pflegel P, et al. Nā ʻāpana o ka pono antimicrobial o ka hua hua grapefruit a me kona pili i nā mea mālama ʻole i loaʻa i loko. Pōpala 1999; 54: 452-6. Nānā kiʻi ʻole.
  153. Ionescu G, Kiehl F, Wichmann-Kunz F, et al. Lawe ʻia ka hua citrus citrus ma atopic eczema: in vitro a me nā ʻike vivo e pili ana i ka microflora ʻōpū. ʻO J Orthomolec Med 1990; 5: 155-7.
  154. Ranzani MR, Fonseca H. ʻO ka loiloi Mycological o ka peanuts unshelled i hoʻomaʻamaʻa ʻia. Hoʻohui Hoʻohui Hoʻohui 1995; 12: 343-6. Nānā kiʻi ʻole.
  155. ʻO Calori-Domingues MA, Fonseca H. ʻO ka loiloi Laboratory o ka kaohi kemikal o ka hana ʻana o aflatoxin i nā peanuts (Arachis hypogaea L.). Hoʻohui Hoʻohui Hoʻohui 1995; 12: 347-50. Nānā kiʻi ʻole.
  156. Sakamoto S, Sato K, Maitani T, Yamada T. [Nānā i nā ʻāpana i nā mea hoʻohui maoli o ka meaʻai "hua hua huaʻulu" na HPLC a me LC / MS]. Eisei Shikenjo Hokoku 1996;: 38-42. Nānā kiʻi ʻole.
  157. Xiong H, Li Y, Slavik MF, Walker JT. ʻO ka pīpī ʻana i ka ʻili moa me nā kemika i koho ʻia e hōʻemi i ka Salmonella typhimurium i hoʻopili ʻia. ʻO J Food Prot 1998; 61: 272-5. Nānā kiʻi ʻole.
  158. He K, Iyer KR, Hayes RN, et al. Hoʻomaʻamaʻa ʻole o ka cytochrome P450 3A4 na bergamottin, kahi ʻāpana o ka wai momona. ʻO Chem Res Toxicol 1998; 11: 252-9. Nānā kiʻi ʻole.
  159. Coreg monograph. I: Gillis MC, Ed. Compendium o nā lāʻau lapaʻau a me nā mea kūikawā (CPS). 34th hua. ʻO Ottawa, ʻo Ontario, CAN: ʻO nā Kauka ʻAmelika ʻo Kanada Assn, 1999: 395.
  160. ʻO Dresser GK, ʻo Spence JD, ʻo Bailey DG. Nā hopena Pharmacokinetic-pharmododynamic a me ka pilina o ke kaohi cytochrome P450 3A4. ʻO Clinic Pharmacokinet 2000; 38: 41-57. Nānā kiʻi ʻole.
  161. Takanaga H, Ohnishi A, Matsuo H, et al. Ka nānā ʻana i ka lāʻau Pharmacokinetic o ka wai wai felodipine-grapefruit e pili ana i kahi hoʻohālikelike kaheima enzyme hiki ʻole ke hoʻohuli ʻia. Br J Clin Pharmacol 2000; 49: 49-58. Nānā kiʻi ʻole.
  162. Takanaga H, Ohnishi A, Murakami H, et al. Ka pilina ma waena o ka manawa ma hope o ka lawe ʻana i ka wai huaʻikuʻi a me ka hopena o ka lāʻau lapaʻau a me nā lāʻau lapaʻau o ka nisoldipine i nā kumuhana olakino. ʻO Clin Pharmacol Ther 2000: 67: 201-14. Nānā kiʻi ʻole.
  163. Damkier P, Hansen LL, Brosen K. Ka hopena o diclofenac, disulfiram, itraconazole, wai momona a me ka erythromycin ma nā pharmacokinetics o quinidine. ʻO Br J Clin Pharmacol 1999; 48: 829-38. Nānā kiʻi ʻole.
  164. van Agtmael MA, Gupta V, van der Graaf CA, van Boxtel CJ. Ka hopena o ka wai momona i ka hāʻule hilinaʻi ʻana o ka manawa o ka wai wai wai artemether i nā kumuhana olakino. ʻO Clin Pharmacol Ther 1999; 66: 408-14. Nānā kiʻi ʻole.
  165. van Agtmael MA, Gupta V, van der Wosten TH, et al. Hoʻonui ka wai momona i ka bioavailability o artemether. Eur J Clin Pharmacol 1999; 55: 405-10. Nānā kiʻi ʻole.
  166. ʻO Oesterheld J, Kallepalli BR. ʻO ka wai huawaina a me clomipramine: ka loli ʻana i ka lakio metabolite. ʻO J Clin Psychopharmacol 1997; 17: 62-3.
  167. Palapala ʻElele o nā Rula Pekelala. Kahi inoa 21. Mahele 182 - Hoʻomaopopo ʻia nā mea maʻamau he palekana. Loaʻa ma: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  168. ʻO Evans AM. Ka hopena o nā meaʻai papa ma ka gastrointestinal metabolism a me ka lawe ʻana o nā lāʻau. ʻO Ther Monit Monit 2000; 22: 131-6. Nānā kiʻi ʻole.
  169. Fuhr U. Nā launa lāʻau me ka wai momona. Lāʻau lapaʻau Saf 1998; 18: 251-72. Nānā kiʻi ʻole.
  170. ʻO Curhan GC, Willett WC, Speizer FE, Stamfer MJ. Hoʻohana inu a me ka makaʻu o nā pōhaku kōkō i nā wahine. Ann Intern Med 1998; 128: 534-40. Nānā kiʻi ʻole.
  171. ʻO Ameer B, Weintraub RA. Nā launa lāʻau me ka wai momona. ʻO Clin Pharmacokinet 1997; 33: 103-21. Nānā kiʻi ʻole.
  172. Lilja JJ, Kivisto KT, Neuvonen PJ. Ka launa ʻana o ka wai hua-simvastatin: hopena ma nā noʻonoʻo serum o simvastatin, ʻākena simvastatin, a me nā mea hoʻohiki HMG-CoA reductase. ʻO Clin Pharmacol Ther 1998; 64: 477-83. Nānā kiʻi ʻole.
  173. Kupferschmidt HH, Fattinger KE, Ha HR, et al. Hoʻonui ka wai momona i ka bioavailability o ka meaola kūpikipiki HIV saquinavir i ke kāne. ʻO Br J Clin Pharmacol 1998; 45: 355-9. Nānā kiʻi ʻole.
  174. Lilja JJ, Kivisto KT, Backman JT, et al. Hoʻonui ka wai momona i ka nui o ka plasma o buspirone. ʻO Clin Pharmacol Ther 1998; 64: 655-60. Nānā kiʻi ʻole.
  175. Fukuda K, Ohta T, Oshima Y, et al. ʻO nā mea kāohi CYP3A4 kikoʻī i ka wai momona: furocoumarin dimers ma ke ʻano he ʻāpana o ka launa lāʻau. Nā lāʻau lapaʻau 1997; 7: 391-6. Nānā kiʻi ʻole.
  176. Zhang YD, Lorenzo B, Reidenberg MM. ʻO ka pāpā ʻana o 11 beta hydroxysteroid dehydrogenase i loaʻa mai ka guinea pig kidney e furosemide, naringenin a me kekahi mau mea hoʻohui ʻē aʻe. ʻO J Steroid Biochem Mol Biol 1994; 49: 81-5. Nānā kiʻi ʻole.
  177. Lee YS, Lorenzo BJ, Koufis T, et al. ʻO ka wai huaʻu a me kāna flavonoids e kāohi i ka 11 beta-hydroxysteroid dehydrogenase. ʻO Clin Pharmacol Ther 1996; 59: 62-71. Nānā kiʻi ʻole.
  178. Zaidenstein R, Dishi V, Gips M, et al. ʻO ka hopena o ka wai huaʻalani ma nā lāʻau lapaʻau lāʻau lapaʻau o ka verapamil i haʻi waha ʻia. Eur J Clin Pharmacol 1998; 54: 337-40. Nānā kiʻi ʻole.
  179. Nā launa lāʻau Grapefruit-drug. Loaʻa ma: www.powernetdesign.com/grapefruit (Loaʻa iā 26 Kepakemapa 1999).
  180. Ozdemir M, Aktan Y, Boydag BS. Ka launa ma waena o ka wai momona a me ka diazepam i loko o ke kanaka. Eur J Mea Hana Lapaʻau Metab Pharmacokinet 1998; 23: 55-9. Nānā kiʻi ʻole.
  181. Lilja JJ, Kivisto KT, Neuvonen PJ. Hoʻonui ka wai momona i ka nui o ke koina o ka atorvastatin a ʻaʻohe ona hopena ma pravastatin. ʻO Clin Pharmacol Ther 1999; 66: 118-27. Nānā kiʻi ʻole.
  182. ʻO Gross AS, Goh YD, Addison RS, et al. Ka hopena o ka wai momona i nā lāʻau lapaʻau cisapride. ʻO Clin Pharmacol Ther 1999; 65: 395-401. Nānā kiʻi ʻole.
  183. Varis T, Kivisto KT, Neuvonen PJ. Hiki i ka wai huaʻalani ke hoʻonui i ka hoʻoliʻiliʻi plasma o ka methylprednisolone. Eur J Clin Pharmacol 2000; 56: 489-93. Nānā kiʻi ʻole.
  184. Cerda JJ, Robbins FL, Burgin CW, a me al. Nā hopena o ka grapepric pectin i nā mea maʻi i ka makaʻu no ka maʻi puʻuwau coronary me ka hoʻololi ʻole i ka papaʻai a me ka nohona. ʻO Clin Cardiol 1988; 11: 589-94. Nānā kiʻi ʻole.
  185. ʻO Dresser GK, Bailey DG, Carruthers SG. ʻO ka launa ʻana o ka wai huaola-felodipine i ka poʻe ʻelemakule olakino. ʻO Clin Pharmacol Ther 1998; 65: (abstract PIII-63).
  186. Zaidenstein R, Avni B, Dishi V, et al. Ka hopena o ka wai huaʻalani ma nā lāʻau lapaʻau lāʻau lapaʻau o losartan i nā mea manawaleʻa olakino. ʻO Clin Pharmacol Ther 1998; 65: (abstract PI-60).
  187. ʻO Soldner A, nā Kristiano U, Susanto M, et al. Hoʻoikaika ka wai huaʻomaʻo i ka lawe lāʻau lāʻau P-glycoprotein. ʻOihana Res 1999; 16: 478-85. Nānā kiʻi ʻole.
  188. Bailey DG, Dresser GK, Kreeft JH, et al. Pākuʻu wai wai-felodipine hui pū: Ka hopena o nā ʻāpana a me kahi unuhi mai nā hua i hana ʻole ʻia. ʻO Clin Pharmacol Ther 2000; 67: 107 (abstract PI-71).
  189. ʻO Veronese M, Burke J, Dorval E, et al. Hoʻopili ka wai huaʻai (GFJ) i ka hopena hepatic a me ka ʻōpū CYP3A4. ʻO Clin Pharmacol Ther 2000; 67: 151 (abstract PIII-37).
  190. Offman EM, Freeman DJ, Dresser GK, et al. ʻO ka launa ʻana ʻo Cisapride me ka wai grapefruit a me ka waina ʻulaʻula. ʻO Clin Pharmacol Ther 2000; 67: 110 (abstract PI-83).
  191. Robbins RC, Martin FG, Roe JM. ʻO kaʻai ʻana i ka huaʻulu i nā mea haʻahaʻa i hoʻokiʻekiʻe ʻia i nā kumuhana kanaka. Int J Vitam Nutr Res 1988; 58: 414-7. Nānā kiʻi ʻole.
  192. Rau SE, Bend JR, Arnold MO, et al. Pākuʻi wai wai huaʻai-terfenadine hui hoʻokahi-nui: ka nui, ka hana, a me ka pilina. ʻO Clin Pharmacol Ther 1997 61: 401-9. Nānā kiʻi ʻole.
  193. Bailey DG, Arnold JM, Ikaika HA, et al. Ka hopena o ka wai huaʻakai a me ka naringin ma nisoldipine pharmacokinetics. ʻO Clin Pharmacol Ther 1993; 54: 589-94. Nānā kiʻi ʻole.
  194. Bailey DG, Spence JD, Munoz C, Arnold JM. Ka launa pū ʻana o nā wai citrus me felodipine a me nifedipine. Lancet 1991; 337: 268-9. Nānā kiʻi ʻole.
  195. Kantola T, Kivisto KT, Neuvonen PJ, et al. Hoʻonui ka wai momona i ka nui o ka lāʻau i ka lovastatin a me ka waikawa lovastatin. ʻO Clin Pharmacol Ther 1998 63: 397-402. Nānā kiʻi ʻole.
  196. ʻO Schubert W, Cullberg G, Edgar B, Hedner T. Kaohi ʻana o ka 17 beta-estradiol ʻōpala e ka wai momona i nā wahine ovariectomized. Maturitas 1994; 20: 155-63. Nānā kiʻi ʻole.
  197. Weber A, Jager R, Hānau ʻA, et al. Hiki i ka wai momona ke hoʻohuli i ka bioavailability ethinylestradiol? Kūpono 1996; 53: 41-7. Nānā kiʻi ʻole.
  198. Garg SK, Kumar N, Bhargava VK, Prabhakar SK. Ka hopena o ka wai huaʻalani ma ka carbamazepine bioavailability i nā mea maʻi me ka maʻi epilepsy. ʻO Clin Pharmacol Ther 1998; 64: 286-8. Nānā kiʻi ʻole.
  199. ʻO Josefsson M, Zackrisson AL, ʻo Ahlner J. Ka hopena o ka wai huaʻalani ma nā lāʻau lapaʻau o ka amlodipine i nā mea manawaleʻa olakino. Eur J Clin Pharmacol 1996; 51: 189-93. Nānā kiʻi ʻole.
  200. Ioannides-Demos LL, Christophidis N, et al. ʻO nā hopena dosing o kahi pilina pilikino ma waena o ka wai momona a me ka cyclosporine a me nā concentrite metabolite i nā mea maʻi me nā maʻi autoimmune. ʻO J Rheumatol 1997; 24: 49-54. Nānā kiʻi ʻole.
  201. Agri Res Svc: Kaukaʻikepili phytochemical a me ethnobotanical a Dr. www.ars-grin.gov/duke (Loaʻa ʻia 3 Nowemapa 1999).
  202. Penzak SR, Gubbins PO, Gurley BJ, et al. Hoʻoemi ka wai momona i ka loaʻa ʻōnaehana o itraconazole capsule i nā mea manawaleʻa olakino. Nā Laikini Lapaʻau Laulaha 1999; 21: 304-9. Nānā kiʻi ʻole.
  203. ʻO Brinker F. Herb Contraindications a me nā launa lāʻau. ʻElua ed. Sandy, OR: Nā Papa Hana Lapaʻau Eclectic, 1998.
Nānā hope - 03/24/2020

NāʻAtikala Hou

Perfectionism: he aha ia a me nā ʻano nui
Ola Kino

Perfectionism: he aha ia a me nā ʻano nui

ʻO Perfectioni m kahi ʻano lawena e hōʻike ʻia e ka makemake e hana i nā hana āpau i kahi ala kūpono, me ka ʻole o ka ʻae ʻana i nā hemahema a i ʻole nā ​​hopena maikaʻi ʻole no kāu hae. He kūlana kiʻ...
Mura: he aha ia, he aha ia a pehea e hoʻohana ai
Ola Kino

Mura: he aha ia, he aha ia a pehea e hoʻohana ai

ʻO Myrrh kahi mea kanu lāʻau o ka lāhui ʻO Commiphora myrrha, i ʻike ʻia he myrrh arabica, nona ka anti eptic, antimicrobial, anti-inflammatory, ane thetic a me nā waiwai a tringent, a hiki ke hoʻohan...